"","ID","Description","GeneRatio","BgRatio","pvalue","p.adjust","qvalue","geneID","Count"
"R-HSA-5663202","R-HSA-5663202","Diseases of signal transduction","48/112","268/2914",2.4028263183078e-22,1.63872754908592e-19,8.67546765452185e-20,"AMER1/APC/AXIN1/CTNNB1/ESR1/GSK3A/GSK3B/KAT2B/MDM2/SMAD3/STAT1/CREBBP/FOXO1/HSP90AA1/MYC/NR4A1/PIK3CA/PIK3R1/SMAD2/AKT1/AKT2/AKT3/EP300/ERBB4/ESR2/GRB2/MAPK1/NOTCH1/SHC1/SRC/STAT3/EGFR/ERBB2/ERBB3/FGF7/FGFR1/FGFR3/FGFR4/MAPK3/MET/PDGFRA/PDGFRB/NCOR1/NCOR2/LCK/FOXO3/TCF7L2/CREB1",48
"R-HSA-212436","R-HSA-212436","Generic Transcription Pathway","58/112","481/2914",1.43241101032135e-18,2.8854234711346e-16,1.52755093471086e-16,"AR/AXIN1/CCNE1/CDK1/CTNNB1/ESR1/GSK3B/KAT2B/MAPK14/MDM2/SMAD3/STAT1/UBE2I/CREBBP/FOXO1/MYC/NR4A1/SMAD2/AKT1/AKT2/AKT3/EP300/ESR2/GATA3/MAPK1/MAPK11/NOTCH1/PML/PPARG/SRC/ABL1/ATR/E2F1/EGFR/ERBB2/MAPK3/MET/ATM/KAT5/TP53/CHEK2/NBN/NCOR1/NCOR2/NR1I2/SIRT1/NR3C1/MYBL2/FOXO3/LEF1/TCF7/TCF7L2/SMAD1/CREB1/SP1/TWIST1/HNF4A/KMT2A",58
"R-HSA-73857","R-HSA-73857","RNA Polymerase II Transcription","59/112","499/2914",1.57575634329699e-18,2.8854234711346e-16,1.52755093471086e-16,"AR/AXIN1/CCNE1/CDK1/CTNNB1/ESR1/GSK3B/KAT2B/MAPK14/MDM2/SMAD3/STAT1/UBE2I/CDC73/CREBBP/FOXO1/MYC/NR4A1/SMAD2/AKT1/AKT2/AKT3/EP300/ESR2/GATA3/MAPK1/MAPK11/NOTCH1/PML/PPARG/SRC/ABL1/ATR/E2F1/EGFR/ERBB2/MAPK3/MET/ATM/KAT5/TP53/CHEK2/NBN/NCOR1/NCOR2/NR1I2/SIRT1/NR3C1/MYBL2/FOXO3/LEF1/TCF7/TCF7L2/SMAD1/CREB1/SP1/TWIST1/HNF4A/KMT2A",59
"R-HSA-2219528","R-HSA-2219528","PI3K/AKT Signaling in Cancer","28/112","97/2914",1.69233048160387e-18,2.8854234711346e-16,1.52755093471086e-16,"ESR1/GSK3A/GSK3B/MDM2/FOXO1/NR4A1/PIK3CA/PIK3R1/AKT1/AKT2/AKT3/ERBB4/ESR2/GRB2/SRC/EGFR/ERBB2/ERBB3/FGF7/FGFR1/FGFR3/FGFR4/MET/PDGFRA/PDGFRB/LCK/FOXO3/CREB1",28
"R-HSA-1257604","R-HSA-1257604","PIP3 activates AKT signaling","34/112","172/2914",8.28414876018675e-17,1.12995789088947e-14,5.9820274205138e-15,"ESR1/GSK3A/GSK3B/MDM2/FOXO1/NR4A1/PIK3CA/PIK3R1/AKT1/AKT2/AKT3/ERBB4/ESR2/GRB2/MAPK1/PML/PPARG/SRC/EGFR/ERBB2/ERBB3/FGF7/FGFR1/FGFR3/FGFR4/INSR/MAPK3/MET/PDGFRA/PDGFRB/TP53/LCK/FOXO3/CREB1",34
"R-HSA-1266738","R-HSA-1266738","Developmental Biology","50/112","397/2914",2.38261584230116e-16,2.70824000741565e-14,1.43374953317421e-14,"CDC42/CTNNB1/GSK3B/KAT2B/MAPK14/PAK1/SMAD3/CREBBP/FOXO1/HSP90AA1/MYC/PIK3CA/PIK3R1/SMAD2/AKT1/AKT2/AKT3/EP300/GRB2/MAPK1/MAPK11/MAPK8/NOTCH1/NR2F2/PML/PPARG/PTK2/SHC1/SRC/STAT3/ABL1/E2F1/EGFR/ERBB2/FGFR1/MAPK3/MET/RET/NCOR1/NCOR2/RELA/FOXO3/LEF1/CREB1/CEBPA/FLI1/MEF2A/HNF4A/KMT2A/MYOD1",50
"R-HSA-9006925","R-HSA-9006925","Intracellular signaling by second messengers","35/112","201/2914",1.76083949418117e-15,1.7155607643308e-13,9.0822247594608e-14,"ESR1/GSK3A/GSK3B/MDM2/FOXO1/NR4A1/PIK3CA/PIK3R1/PRKCD/AKT1/AKT2/AKT3/ERBB4/ESR2/GRB2/MAPK1/PML/PPARG/SRC/EGFR/ERBB2/ERBB3/FGF7/FGFR1/FGFR3/FGFR4/INSR/MAPK3/MET/PDGFRA/PDGFRB/TP53/LCK/FOXO3/CREB1",35
"R-HSA-8939211","R-HSA-8939211","ESR-mediated signaling","25/112","108/2914",4.65202773488367e-14,3.96585364398833e-12,2.0995335698225e-12,"AXIN1/ESR1/KAT2B/CREBBP/HSP90AA1/MYC/PIK3CA/PIK3R1/AKT1/AKT2/AKT3/EP300/ERBB4/ESR2/GATA3/MAPK1/PTK2/SHC1/SRC/EGFR/MAPK3/KAT5/FOXO3/CREB1/SP1",25
"R-HSA-199418","R-HSA-199418","Negative regulation of the PI3K/AKT network","24/112","99/2914",5.32940690911685e-14,4.0385061244641e-12,2.13799598810185e-12,"ESR1/PIK3CA/PIK3R1/AKT1/AKT2/AKT3/ERBB4/ESR2/GRB2/MAPK1/SRC/EGFR/ERBB2/ERBB3/FGF7/FGFR1/FGFR3/FGFR4/INSR/MAPK3/MET/PDGFRA/PDGFRB/LCK",24
"R-HSA-1643685","R-HSA-1643685","Disease","49/112","443/2914",1.28839824621045e-13,8.78687603915524e-12,4.65179577315982e-12,"AMER1/APC/AXIN1/CTNNB1/ESR1/GSK3A/GSK3B/KAT2B/MDM2/SMAD3/STAT1/CREBBP/FOXO1/HSP90AA1/MYC/NR4A1/PIK3CA/PIK3R1/SMAD2/AKT1/AKT2/AKT3/EP300/ERBB4/ESR2/GRB2/MAPK1/NOTCH1/SHC1/SRC/STAT3/EGFR/ERBB2/ERBB3/FGF7/FGFR1/FGFR3/FGFR4/MAPK3/MET/PDGFRA/PDGFRB/NCOR1/NCOR2/RELA/LCK/FOXO3/TCF7L2/CREB1",49
"R-HSA-9006931","R-HSA-9006931","Signaling by Nuclear Receptors","27/112","136/2914",2.17766436912262e-13,1.35015190885602e-11,7.14774046515845e-12,"AXIN1/ESR1/KAT2B/CREBBP/HSP90AA1/MYC/PIK3CA/PIK3R1/AKT1/AKT2/AKT3/EP300/ERBB4/ESR2/GATA3/MAPK1/PTK2/SHC1/SRC/EGFR/MAPK3/KAT5/NCOR1/NCOR2/FOXO3/CREB1/SP1",27
"R-HSA-6811558","R-HSA-6811558","PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling","22/112","92/2914",9.49344138280825e-13,5.39543918589602e-11,2.85635999500283e-11,"ESR1/PIK3CA/PIK3R1/AKT1/ERBB4/ESR2/GRB2/MAPK1/SRC/EGFR/ERBB2/ERBB3/FGF7/FGFR1/FGFR3/FGFR4/INSR/MAPK3/MET/PDGFRA/PDGFRB/LCK",22
"R-HSA-2219530","R-HSA-2219530","Constitutive Signaling by Aberrant PI3K in Cancer","18/112","72/2914",6.32910410590944e-11,3.32034538479249e-09,1.75779976382748e-09,"ESR1/PIK3CA/PIK3R1/ERBB4/ESR2/GRB2/SRC/EGFR/ERBB2/ERBB3/FGF7/FGFR1/FGFR3/FGFR4/MET/PDGFRA/PDGFRB/LCK",18
"R-HSA-1227986","R-HSA-1227986","Signaling by ERBB2","14/112","44/2914",2.9767530369322e-10,1.45010397941983e-08,7.67688941103567e-09,"HSP90AA1/PIK3CA/PIK3R1/PRKCD/AKT1/AKT2/AKT3/ERBB4/GRB2/SHC1/SRC/EGFR/ERBB2/ERBB3",14
"R-HSA-9006934","R-HSA-9006934","Signaling by Receptor Tyrosine Kinases","38/112","347/2914",3.49175188424483e-10,1.58758319003665e-08,8.4047080441823e-09,"CDC42/CTNNB1/ESR1/MAPK14/PAK1/STAT1/HSP90AA1/PIK3CA/PIK3R1/PRKCD/AKT1/AKT2/AKT3/ERBB4/GRB2/MAPK1/MAPK11/PTK2/SHC1/SRC/STAT3/EGFR/ERBB2/ERBB3/FGF7/FGFR1/FGFR3/FGFR4/INSR/MAPK3/MET/NTRK1/PDGFRA/PDGFRB/NCOR1/LCK/CREB1/MEF2A",38
"R-HSA-9009391","R-HSA-9009391","Extra-nuclear estrogen signaling","16/112","63/2914",6.3016710583442e-10,2.68608728861922e-08,1.42202182435004e-08,"ESR1/HSP90AA1/PIK3CA/PIK3R1/AKT1/AKT2/AKT3/ESR2/MAPK1/PTK2/SHC1/SRC/EGFR/MAPK3/FOXO3/CREB1",16
"R-HSA-8878159","R-HSA-8878159","Transcriptional regulation by RUNX3","14/112","53/2914",4.65752298171622e-09,1.79662636051125e-07,9.51138820273743e-08,"CTNNB1/KAT2B/MDM2/SMAD3/CREBBP/MYC/EP300/NOTCH1/SRC/TP53/FOXO3/LEF1/TCF7/TCF7L2",14
"R-HSA-8878166","R-HSA-8878166","Transcriptional regulation by RUNX2","15/112","62/2914",4.74182910398863e-09,1.79662636051125e-07,9.51138820273743e-08,"AR/CDK1/ESR1/GSK3B/STAT1/AKT1/AKT2/AKT3/MAPK1/SRC/ABL1/MAPK3/NR3C1/SMAD1/TWIST1",15
"R-HSA-5674400","R-HSA-5674400","Constitutive Signaling by AKT1 E17K in Cancer","10/112","24/2914",5.88208952649976e-09,2.11136055635412e-07,1.117759948803e-07,"GSK3A/GSK3B/MDM2/FOXO1/NR4A1/AKT1/AKT2/AKT3/FOXO3/CREB1",10
"R-HSA-2262752","R-HSA-2262752","Cellular responses to stress","25/112","187/2914",1.45897162918958e-08,4.97509325553647e-07,2.63382773058961e-07,"AR/CCNE1/GSK3B/MAPK14/MDM2/CREBBP/HSP90AA1/EP300/MAPK1/MAPK11/MAPK8/STAT3/ATR/E2F1/MAPK3/ATM/KAT5/TP53/NBN/RELA/SIRT1/NR3C1/ARNT/HIF1A/SP1",25
"R-HSA-8953897","R-HSA-8953897","Cellular responses to external stimuli","25/112","189/2914",1.82345119999672e-08,5.92187484951315e-07,3.13505644911716e-07,"AR/CCNE1/GSK3B/MAPK14/MDM2/CREBBP/HSP90AA1/EP300/MAPK1/MAPK11/MAPK8/STAT3/ATR/E2F1/MAPK3/ATM/KAT5/TP53/NBN/RELA/SIRT1/NR3C1/ARNT/HIF1A/SP1",25
"R-HSA-9616222","R-HSA-9616222","Transcriptional regulation of granulopoiesis","10/112","27/2914",2.29535156224314e-08,7.11558984295374e-07,3.76701237248516e-07,"MYC/EP300/PML/STAT3/E2F1/LEF1/CREB1/CEBPA/FLI1/KMT2A",10
"R-HSA-201722","R-HSA-201722","Formation of the beta-catenin:TCF transactivating complex","9/112","22/2914",4.34828116790057e-08,1.28935989413399e-06,6.82590590658991e-07,"CTNNB1/CDC73/CREBBP/MYC/EP300/KAT5/LEF1/TCF7/TCF7L2",9
"R-HSA-389356","R-HSA-389356","CD28 co-stimulation","10/112","31/2914",1.05976845702787e-07,2.80991114634003e-06,1.48757450716875e-06,"CDC42/PAK1/PIK3CA/PIK3R1/AKT1/AKT2/AKT3/GRB2/SRC/LCK",10
"R-HSA-186712","R-HSA-186712","Regulation of beta-cell development","9/112","24/2914",1.07122712323814e-07,2.80991114634003e-06,1.48757450716875e-06,"KAT2B/CREBBP/FOXO1/AKT1/AKT2/AKT3/EP300/NOTCH1/HNF4A",9
"R-HSA-9634638","R-HSA-9634638","Estrogen-dependent nuclear events downstream of ESR-membrane signaling","9/112","24/2914",1.07122712323814e-07,2.80991114634003e-06,1.48757450716875e-06,"AKT1/AKT2/AKT3/MAPK1/PTK2/EGFR/MAPK3/FOXO3/CREB1",9
"R-HSA-9614085","R-HSA-9614085","FOXO-mediated transcription","12/112","49/2914",1.60681790380816e-07,4.05870300147099e-06,2.14868826903002e-06,"KAT2B/SMAD3/CREBBP/FOXO1/SMAD2/AKT1/AKT2/AKT3/EP300/SIRT1/NR3C1/FOXO3",12
"R-HSA-5683057","R-HSA-5683057","MAPK family signaling cascades","24/112","202/2914",3.06683629076401e-07,7.41274276853698e-06,3.92432592932271e-06,"CDC42/CDK1/PAK1/FOXO1/MYC/ERBB4/GRB2/MAPK1/PTK2/SHC1/SRC/EGFR/ERBB2/ERBB3/FGF7/FGFR1/FGFR3/FGFR4/MAPK3/MET/PDGFRA/PDGFRB/RET/FOXO3",24
"R-HSA-74751","R-HSA-74751","Insulin receptor signalling cascade","12/112","52/2914",3.26073728821275e-07,7.41274276853698e-06,3.92432592932271e-06,"PIK3CA/PIK3R1/AKT2/GRB2/MAPK1/SHC1/FGF7/FGFR1/FGFR3/FGFR4/INSR/MAPK3",12
"R-HSA-74752","R-HSA-74752","Signaling by Insulin receptor","12/112","52/2914",3.26073728821275e-07,7.41274276853698e-06,3.92432592932271e-06,"PIK3CA/PIK3R1/AKT2/GRB2/MAPK1/SHC1/FGF7/FGFR1/FGFR3/FGFR4/INSR/MAPK3",12
"R-HSA-9617629","R-HSA-9617629","Regulation of FOXO transcriptional activity by acetylation","6/112","10/2914",5.23089677084148e-07,1.15079728958513e-05,6.0923517568714e-06,"KAT2B/CREBBP/FOXO1/EP300/SIRT1/FOXO3",6
"R-HSA-1963642","R-HSA-1963642","PI3K events in ERBB2 signaling","7/112","16/2914",8.83470444902668e-07,1.88289638569881e-05,9.96810403294787e-06,"PIK3CA/PIK3R1/ERBB4/GRB2/EGFR/ERBB2/ERBB3",7
"R-HSA-157118","R-HSA-157118","Signaling by NOTCH","16/112","104/2914",1.22390369210464e-06,2.52940096368291e-05,1.33907166313203e-05,"KAT2B/SMAD3/STAT1/CREBBP/MYC/AKT1/EP300/NOTCH1/E2F1/EGFR/TP53/NCOR1/NCOR2/CREB1/HIF1A/IKZF1",16
"R-HSA-9018519","R-HSA-9018519","Estrogen-dependent gene expression","11/112","49/2914",1.40852869076547e-06,2.8253428444178e-05,1.49574408957448e-05,"AXIN1/ESR1/KAT2B/CREBBP/HSP90AA1/MYC/EP300/ERBB4/GATA3/KAT5/SP1",11
"R-HSA-187037","R-HSA-187037","Signaling by NTRK1 (TRKA)","13/112","70/2914",1.49567012511778e-06,2.91442007237235e-05,1.54290181327939e-05,"MAPK14/PIK3CA/PIK3R1/GRB2/MAPK1/MAPK11/SHC1/SRC/STAT3/MAPK3/NTRK1/CREB1/MEF2A",13
"R-HSA-8863795","R-HSA-8863795","Downregulation of ERBB2 signaling","8/112","24/2914",1.63321558589653e-06,3.09403619328176e-05,1.63799107006582e-05,"HSP90AA1/AKT1/AKT2/AKT3/ERBB4/EGFR/ERBB2/ERBB3",8
"R-HSA-5633007","R-HSA-5633007","Regulation of TP53 Activity","15/112","95/2914",1.94114640216922e-06,3.57800498994434e-05,1.89420545076541e-05,"CDK1/MAPK14/MDM2/AKT1/AKT2/AKT3/EP300/MAPK11/PML/ATR/ATM/KAT5/TP53/CHEK2/NBN",15
"R-HSA-201681","R-HSA-201681","TCF dependent signaling in response to WNT","16/112","108/2914",2.06345972071464e-06,3.70336718296681e-05,1.96057253242416e-05,"AMER1/APC/AXIN1/CTNNB1/GSK3B/CDC73/CREBBP/MYC/AKT1/AKT2/EP300/KAT5/LEF1/TCF7/TCF7L2/SOX6",16
"R-HSA-8864260","R-HSA-8864260","Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors","8/112","25/2914",2.32553306943387e-06,4.06670141885615e-05,2.15292265267427e-05,"ESR1/UBE2I/CREBBP/MYC/EP300/EGFR/ERBB2/MYBL2",8
"R-HSA-2029480","R-HSA-2029480","Fcgamma receptor (FCGR) dependent phagocytosis","12/112","62/2914",2.46664847386773e-06,4.20563564794448e-05,2.22647480667535e-05,"CDC42/PAK1/HSP90AA1/PIK3CA/PIK3R1/PRKCD/GRB2/MAPK1/PTK2/SRC/ABL1/MAPK3",12
"R-HSA-4420097","R-HSA-4420097","VEGFA-VEGFR2 Pathway","14/112","85/2914",2.61606335860124e-06,4.35159807455134e-05,2.30374770731765e-05,"CDC42/CTNNB1/MAPK14/PAK1/HSP90AA1/PIK3CA/PIK3R1/PRKCD/AKT1/AKT2/AKT3/MAPK11/PTK2/SRC",14
"R-HSA-2559583","R-HSA-2559583","Cellular Senescence","15/112","99/2914",3.32767399974139e-06,5.4035087329134e-05,2.8606320348654e-05,"CCNE1/MAPK14/MDM2/MAPK1/MAPK11/MAPK8/STAT3/E2F1/MAPK3/ATM/KAT5/TP53/NBN/RELA/SP1",15
"R-HSA-198323","R-HSA-198323","AKT phosphorylates targets in the cytosol","6/112","13/2914",3.88685155222063e-06,6.02548186141748e-05,3.18990627946627e-05,"GSK3A/GSK3B/MDM2/AKT1/AKT2/AKT3",6
"R-HSA-1236394","R-HSA-1236394","Signaling by ERBB4","10/112","44/2914",3.88740765252741e-06,6.02548186141748e-05,3.18990627946627e-05,"ESR1/PIK3CA/PIK3R1/ERBB4/GRB2/SHC1/SRC/EGFR/ERBB3/NCOR1",10
"R-HSA-190236","R-HSA-190236","Signaling by FGFR","11/112","55/2914",4.75985744971484e-06,7.21382840156783e-05,3.81902012924489e-05,"PIK3CA/PIK3R1/GRB2/MAPK1/SHC1/SRC/FGF7/FGFR1/FGFR3/FGFR4/MAPK3",11
"R-HSA-9607240","R-HSA-9607240","FLT3 Signaling","21/112","188/2914",5.33785115467186e-06,7.9139445380135e-05,4.18966349211087e-05,"PIK3CA/PIK3R1/AKT2/ERBB4/GRB2/MAPK1/PTK2/SHC1/SRC/EGFR/ERBB2/ERBB3/FGF7/FGFR1/FGFR3/FGFR4/MAPK3/MET/PDGFRA/PDGFRB/RET",21
"R-HSA-383280","R-HSA-383280","Nuclear Receptor transcription pathway","10/112","46/2914",5.98495603228474e-06,8.68455322131531e-05,4.59762579859724e-05,"AR/ESR1/NR4A1/ESR2/PPARG/NCOR1/NCOR2/NR1I2/NR3C1/HNF4A",10
"R-HSA-5637810","R-HSA-5637810","Constitutive Signaling by EGFRvIII","6/112","14/2914",6.59004612139664e-06,8.98882290958502e-05,4.75870698871378e-05,"HSP90AA1/PIK3CA/PIK3R1/GRB2/SHC1/EGFR",6
"R-HSA-5637812","R-HSA-5637812","Signaling by EGFRvIII in Cancer","6/112","14/2914",6.59004612139664e-06,8.98882290958502e-05,4.75870698871378e-05,"HSP90AA1/PIK3CA/PIK3R1/GRB2/SHC1/EGFR",6
"R-HSA-6804758","R-HSA-6804758","Regulation of TP53 Activity through Acetylation","6/112","14/2914",6.59004612139664e-06,8.98882290958502e-05,4.75870698871378e-05,"AKT1/AKT2/AKT3/EP300/PML/TP53",6
"R-HSA-194138","R-HSA-194138","Signaling by VEGF","14/112","92/2914",6.91389554425154e-06,9.2456407081952e-05,4.8946670210078e-05,"CDC42/CTNNB1/MAPK14/PAK1/HSP90AA1/PIK3CA/PIK3R1/PRKCD/AKT1/AKT2/AKT3/MAPK11/PTK2/SRC",14
"R-HSA-186763","R-HSA-186763","Downstream signal transduction","8/112","29/2914",8.11172737968234e-06,0.000102448112461914,5.42363058719502e-05,"STAT1/PIK3CA/PIK3R1/GRB2/SRC/STAT3/PDGFRA/PDGFRB",8
"R-HSA-6804757","R-HSA-6804757","Regulation of TP53 Degradation","8/112","29/2914",8.11172737968234e-06,0.000102448112461914,5.42363058719502e-05,"CDK1/MDM2/AKT1/AKT2/AKT3/ATM/TP53/CHEK2",8
"R-HSA-6806003","R-HSA-6806003","Regulation of TP53 Expression and Degradation","8/112","29/2914",8.11172737968234e-06,0.000102448112461914,5.42363058719502e-05,"CDK1/MDM2/AKT1/AKT2/AKT3/ATM/TP53/CHEK2",8
"R-HSA-3108232","R-HSA-3108232","SUMO E3 ligases SUMOylate target proteins","15/112","107/2914",8.99503645917322e-06,0.000111538452093748,5.90487560860558e-05,"AR/ESR1/MDM2/PIAS1/UBE2I/CREBBP/EP300/PML/PPARG/TP53/NCOR2/NR1I2/RELA/NR3C1/TDG",15
"R-HSA-1250196","R-HSA-1250196","SHC1 events in ERBB2 signaling","7/112","22/2914",1.08679205783467e-05,0.000130033716393552,6.88401986772471e-05,"PRKCD/ERBB4/GRB2/SHC1/EGFR/ERBB2/ERBB3",7
"R-HSA-525793","R-HSA-525793","Myogenesis","7/112","22/2914",1.08679205783467e-05,0.000130033716393552,6.88401986772471e-05,"CDC42/CTNNB1/MAPK14/MAPK11/ABL1/MEF2A/MYOD1",7
"R-HSA-2990846","R-HSA-2990846","SUMOylation","15/112","109/2914",1.13531352167913e-05,0.000133497210652615,7.06737818395539e-05,"AR/ESR1/MDM2/PIAS1/UBE2I/CREBBP/EP300/PML/PPARG/TP53/NCOR2/NR1I2/RELA/NR3C1/TDG",15
"R-HSA-3769402","R-HSA-3769402","Deactivation of the beta-catenin transactivating complex","8/112","31/2914",1.39780237210054e-05,0.000159592535737433,8.44887170210516e-05,"APC/CTNNB1/AKT1/AKT2/LEF1/TCF7/TCF7L2/SOX6",8
"R-HSA-1640170","R-HSA-1640170","Cell Cycle","24/112","249/2914",1.40403990384838e-05,0.000159592535737433,8.44887170210516e-05,"CCNE1/CDK1/GSK3B/MDM2/UBE2I/HSP90AA1/MYC/AKT1/AKT2/AKT3/EP300/MAPK1/SRC/ABL1/ATR/E2F1/MAPK3/ATM/KAT5/TP53/CHEK2/NBN/MYBL2/FOXM1",24
"R-HSA-1236382","R-HSA-1236382","Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants","6/112","16/2914",1.64960242486962e-05,0.000176732197683262,9.35625000854436e-05,"HSP90AA1/PIK3CA/PIK3R1/GRB2/SHC1/EGFR",6
"R-HSA-5637815","R-HSA-5637815","Signaling by Ligand-Responsive EGFR Variants in Cancer","6/112","16/2914",1.64960242486962e-05,0.000176732197683262,9.35625000854436e-05,"HSP90AA1/PIK3CA/PIK3R1/GRB2/SHC1/EGFR",6
"R-HSA-450341","R-HSA-450341","Activation of the AP-1 family of transcription factors","5/112","10/2914",1.65848396652915e-05,0.000176732197683262,9.35625000854436e-05,"MAPK14/MAPK1/MAPK11/MAPK8/MAPK3",5
"R-HSA-74749","R-HSA-74749","Signal attenuation","5/112","10/2914",1.65848396652915e-05,0.000176732197683262,9.35625000854436e-05,"GRB2/MAPK1/SHC1/INSR/MAPK3",5
"R-HSA-388841","R-HSA-388841","Costimulation by the CD28 family","10/112","53/2914",2.2809672153162e-05,0.000238346244278864,0.000126181141823816,"CDC42/PAK1/PIK3CA/PIK3R1/AKT1/AKT2/AKT3/GRB2/SRC/LCK",10
"R-HSA-187687","R-HSA-187687","Signalling to ERKs","8/112","33/2914",2.3065765575374e-05,0.000238346244278864,0.000126181141823816,"MAPK14/GRB2/MAPK1/MAPK11/SHC1/SRC/MAPK3/NTRK1",8
"R-HSA-166520","R-HSA-166520","Signaling by NTRKs","13/112","89/2914",2.39059276370958e-05,0.000243340935052229,0.000128825344532975,"MAPK14/PIK3CA/PIK3R1/GRB2/MAPK1/MAPK11/SHC1/SRC/STAT3/MAPK3/NTRK1/CREB1/MEF2A",13
"R-HSA-5684996","R-HSA-5684996","MAPK1/MAPK3 signaling","19/112","177/2914",2.86268752036117e-05,0.000279207569046483,0.000147813236892952,"CDK1/ERBB4/GRB2/MAPK1/PTK2/SHC1/SRC/EGFR/ERBB2/ERBB3/FGF7/FGFR1/FGFR3/FGFR4/MAPK3/MET/PDGFRA/PDGFRB/RET",19
"R-HSA-5693565","R-HSA-5693565","Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks","8/112","34/2914",2.92066542948352e-05,0.000279207569046483,0.000147813236892952,"UBE2I/MAPK8/ABL1/ATM/KAT5/TP53/CHEK2/NBN",8
"R-HSA-1358803","R-HSA-1358803","Downregulation of ERBB2:ERBB3 signaling","5/112","11/2914",2.9476458902268e-05,0.000279207569046483,0.000147813236892952,"AKT1/AKT2/AKT3/ERBB2/ERBB3",5
"R-HSA-210745","R-HSA-210745","Regulation of gene expression in beta cells","5/112","11/2914",2.9476458902268e-05,0.000279207569046483,0.000147813236892952,"FOXO1/AKT1/AKT2/AKT3/HNF4A",5
"R-HSA-9614399","R-HSA-9614399","Regulation of localization of FOXO transcription factors","5/112","11/2914",2.9476458902268e-05,0.000279207569046483,0.000147813236892952,"FOXO1/AKT1/AKT2/AKT3/FOXO3",5
"R-HSA-9013508","R-HSA-9013508","NOTCH3 Intracellular Domain Regulates Transcription","6/112","18/2914",3.58981687945788e-05,0.000334398622600208,0.000177031528865367,"KAT2B/STAT1/CREBBP/EP300/NOTCH1/IKZF1",6
"R-HSA-5693606","R-HSA-5693606","DNA Double Strand Break Response","8/112","35/2914",3.66603791006171e-05,0.000334398622600208,0.000177031528865367,"UBE2I/MAPK8/ABL1/ATM/KAT5/TP53/CHEK2/NBN",8
"R-HSA-1226099","R-HSA-1226099","Signaling by FGFR in disease","9/112","45/2914",3.67740420748029e-05,0.000334398622600208,0.000177031528865367,"STAT1/PIK3CA/PIK3R1/GRB2/STAT3/FGF7/FGFR1/FGFR3/FGFR4",9
"R-HSA-6785807","R-HSA-6785807","Interleukin-4 and Interleukin-13 signaling","13/112","94/2914",4.35329653515896e-05,0.000390651083812949,0.000206811732902981,"STAT1/FOXO1/HSP90AA1/MYC/PIK3R1/AKT1/GATA3/STAT3/PIM1/TP53/FOXO3/HIF1A/TWIST1",13
"R-HSA-1839117","R-HSA-1839117","Signaling by cytosolic FGFR1 fusion mutants","5/112","12/2914",4.89880302448421e-05,0.000433893982168601,0.000229704639425575,"STAT1/PIK3CA/PIK3R1/GRB2/STAT3",5
"R-HSA-8848021","R-HSA-8848021","Signaling by PTK6","9/112","47/2914",5.30036087414329e-05,0.000457575457742497,0.000242241676193358,"CCNE1/AKT1/ERBB4/STAT3/EGFR/ERBB2/ERBB3/NR3C1/HIF1A",9
"R-HSA-9006927","R-HSA-9006927","Signaling by Non-Receptor Tyrosine Kinases","9/112","47/2914",5.30036087414329e-05,0.000457575457742497,0.000242241676193358,"CCNE1/AKT1/ERBB4/STAT3/EGFR/ERBB2/ERBB3/NR3C1/HIF1A",9
"R-HSA-5688426","R-HSA-5688426","Deubiquitination","15/112","124/2914",5.48431110499644e-05,0.000467537521700946,0.000247515619607076,"APC/AR/AXIN1/CDK1/ESR1/KAT2B/MDM2/SMAD3/MYC/SMAD2/EP300/GATA3/TP53/SMAD1/HIF1A",15
"R-HSA-195253","R-HSA-195253","Degradation of beta-catenin by the destruction complex","8/112","37/2914",5.6386421630592e-05,0.000468969994537362,0.000248273974573723,"AMER1/APC/AXIN1/CTNNB1/GSK3B/LEF1/TCF7/TCF7L2",8
"R-HSA-5654741","R-HSA-5654741","Signaling by FGFR3","8/112","37/2914",5.6386421630592e-05,0.000468969994537362,0.000248273974573723,"PIK3CA/PIK3R1/GRB2/MAPK1/SHC1/SRC/FGFR3/MAPK3",8
"R-HSA-4090294","R-HSA-4090294","SUMOylation of intracellular receptors","7/112","28/2914",6.22810825518047e-05,0.000506213840482976,0.00026799096663939,"AR/ESR1/PIAS1/UBE2I/PPARG/NR1I2/NR3C1",7
"R-HSA-5673001","R-HSA-5673001","RAF/MAP kinase cascade","18/112","171/2914",6.23489187691642e-05,0.000506213840482976,0.00026799096663939,"ERBB4/GRB2/MAPK1/PTK2/SHC1/SRC/EGFR/ERBB2/ERBB3/FGF7/FGFR1/FGFR3/FGFR4/MAPK3/MET/PDGFRA/PDGFRB/RET",18
"R-HSA-195721","R-HSA-195721","Signaling by WNT","18/112","172/2914",6.7425003056241e-05,0.000540986495110075,0.000286399703384404,"AMER1/APC/AXIN1/CTNNB1/GSK3B/CDC73/CREBBP/MYC/AKT1/AKT2/EP300/ROR2/KAT5/NFATC1/LEF1/TCF7/TCF7L2/SOX6",18
"R-HSA-5654743","R-HSA-5654743","Signaling by FGFR4","8/112","38/2914",6.9160081183288e-05,0.000548455527523284,0.000290353829202788,"PIK3CA/PIK3R1/GRB2/MAPK1/SHC1/SRC/FGFR4/MAPK3",8
"R-HSA-167044","R-HSA-167044","Signalling to RAS","6/112","20/2914",7.03645668572361e-05,0.000551593501110748,0.000292015080847332,"MAPK14/GRB2/MAPK11/SHC1/SRC/NTRK1",6
"R-HSA-109606","R-HSA-109606","Intrinsic Pathway for Apoptosis","9/112","49/2914",7.49062311518516e-05,0.000574000557815312,0.000303877436843112,"AKT1/AKT2/AKT3/MAPK1/MAPK8/STAT3/E2F1/MAPK3/TP53",9
"R-HSA-3371556","R-HSA-3371556","Cellular response to heat stress","9/112","49/2914",7.49062311518516e-05,0.000574000557815312,0.000303877436843112,"GSK3B/CREBBP/HSP90AA1/EP300/MAPK1/ATR/MAPK3/ATM/SIRT1",9
"R-HSA-6804760","R-HSA-6804760","Regulation of TP53 Activity through Methylation","5/112","13/2914",7.71762669277307e-05,0.000584824600496804,0.000309607714107738,"MDM2/EP300/ATM/TP53/CHEK2",5
"R-HSA-449147","R-HSA-449147","Signaling by Interleukins","27/112","332/2914",8.44921078684913e-05,0.000633226566662759,0.000335231844984297,"CDC42/MAPK14/SMAD3/STAT1/FOXO1/HSP90AA1/MYC/PIK3CA/PIK3R1/AKT1/GATA3/GRB2/MAPK1/MAPK11/MAPK8/SHC1/STAT3/MAPK3/PIM1/TP53/RELA/LCK/FOXO3/CREB1/HIF1A/TWIST1/MEF2A",27
"R-HSA-109581","R-HSA-109581","Apoptosis","13/112","101/2914",9.39330438020908e-05,0.000692520316576556,0.000366622115427934,"APC/CTNNB1/PRKCD/AKT1/AKT2/AKT3/MAPK1/MAPK8/PTK2/STAT3/E2F1/MAPK3/TP53",13
"R-HSA-389357","R-HSA-389357","CD28 dependent PI3K/Akt signaling","6/112","21/2914",9.54500143082057e-05,0.000692520316576556,0.000366622115427934,"PIK3CA/PIK3R1/AKT1/AKT2/AKT3/LCK",6
"R-HSA-397795","R-HSA-397795","G-protein beta:gamma signalling","6/112","21/2914",9.54500143082057e-05,0.000692520316576556,0.000366622115427934,"CDC42/PAK1/AKT1/AKT2/AKT3/PIK3CG",6
"R-HSA-2871796","R-HSA-2871796","FCERI mediated MAPK activation","7/112","30/2914",0.000100457822562463,0.000709113138103553,0.000375406399706002,"MAP3K1/PAK1/GRB2/MAPK1/MAPK8/SHC1/MAPK3",7
"R-HSA-450282","R-HSA-450282","MAPK targets/ Nuclear events mediated by MAP kinases","7/112","30/2914",0.000100457822562463,0.000709113138103553,0.000375406399706002,"MAPK14/MAPK1/MAPK11/MAPK8/MAPK3/CREB1/MEF2A",7
"R-HSA-2122947","R-HSA-2122947","NOTCH1 Intracellular Domain Regulates Transcription","8/112","40/2914",0.000101979701925794,0.000709113138103553,0.000375406399706002,"KAT2B/CREBBP/MYC/EP300/NOTCH1/NCOR1/NCOR2/HIF1A",8
"R-HSA-381340","R-HSA-381340","Transcriptional regulation of white adipocyte differentiation","8/112","40/2914",0.000101979701925794,0.000709113138103553,0.000375406399706002,"CREBBP/EP300/NR2F2/PPARG/NCOR1/NCOR2/RELA/CEBPA",8
"R-HSA-2404192","R-HSA-2404192","Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)","9/112","51/2914",0.000103975533446269,0.000709113138103553,0.000375406399706002,"PIK3CA/PIK3R1/AKT2/GRB2/SHC1/FGF7/FGFR1/FGFR3/FGFR4",9
"R-HSA-2428924","R-HSA-2428924","IGF1R signaling cascade","9/112","51/2914",0.000103975533446269,0.000709113138103553,0.000375406399706002,"PIK3CA/PIK3R1/AKT2/GRB2/SHC1/FGF7/FGFR1/FGFR3/FGFR4",9
"R-HSA-5357801","R-HSA-5357801","Programmed Cell Death","13/112","103/2914",0.00011544351678469,0.000741855596419531,0.000392740345071615,"APC/CTNNB1/PRKCD/AKT1/AKT2/AKT3/MAPK1/MAPK8/PTK2/STAT3/E2F1/MAPK3/TP53",13
"R-HSA-4839743","R-HSA-4839743","phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex","5/112","14/2914",0.00011639083404236,0.000741855596419531,0.000392740345071615,"AMER1/APC/AXIN1/CTNNB1/GSK3B",5
"R-HSA-5339716","R-HSA-5339716","Misspliced GSK3beta mutants stabilize beta-catenin","5/112","14/2914",0.00011639083404236,0.000741855596419531,0.000392740345071615,"AMER1/APC/AXIN1/CTNNB1/GSK3B",5
"R-HSA-5358747","R-HSA-5358747","S33 mutants of beta-catenin aren't phosphorylated","5/112","14/2914",0.00011639083404236,0.000741855596419531,0.000392740345071615,"AMER1/APC/AXIN1/CTNNB1/GSK3B",5
"R-HSA-5358749","R-HSA-5358749","S37 mutants of beta-catenin aren't phosphorylated","5/112","14/2914",0.00011639083404236,0.000741855596419531,0.000392740345071615,"AMER1/APC/AXIN1/CTNNB1/GSK3B",5
"R-HSA-5358751","R-HSA-5358751","S45 mutants of beta-catenin aren't phosphorylated","5/112","14/2914",0.00011639083404236,0.000741855596419531,0.000392740345071615,"AMER1/APC/AXIN1/CTNNB1/GSK3B",5
"R-HSA-5358752","R-HSA-5358752","T41 mutants of beta-catenin aren't phosphorylated","5/112","14/2914",0.00011639083404236,0.000741855596419531,0.000392740345071615,"AMER1/APC/AXIN1/CTNNB1/GSK3B",5
"R-HSA-400253","R-HSA-400253","Circadian Clock","9/112","52/2914",0.000121736728376079,0.00076765896391261,0.000406400717119965,"CREBBP/EP300/PPP1CA/NCOR1/SIRT1/NR3C1/CREB1/HIF1A/CREM",9
"R-HSA-5654736","R-HSA-5654736","Signaling by FGFR1","8/112","41/2914",0.000122690362267558,0.00076765896391261,0.000406400717119965,"PIK3CA/PIK3R1/GRB2/MAPK1/SHC1/SRC/FGFR1/MAPK3",8
"R-HSA-1643713","R-HSA-1643713","Signaling by EGFR in Cancer","6/112","22/2914",0.000127168299456903,0.000788443456632796,0.000417404083384857,"HSP90AA1/PIK3CA/PIK3R1/GRB2/SHC1/EGFR",6
"R-HSA-109704","R-HSA-109704","PI3K Cascade","8/112","42/2914",0.00014676092345529,0.000901720268437009,0.000477373131770171,"PIK3CA/PIK3R1/AKT2/GRB2/FGF7/FGFR1/FGFR3/FGFR4",8
"R-HSA-375165","R-HSA-375165","NCAM signaling for neurite out-growth","7/112","32/2914",0.000155818842175647,0.00094882544967671,0.000502310741224127,"GRB2/MAPK1/PTK2/SRC/FGFR1/MAPK3/CREB1",7
"R-HSA-1912408","R-HSA-1912408","Pre-NOTCH Transcription and Translation","6/112","23/2914",0.000166710996009949,0.00099734122174373,0.000527995121250347,"KAT2B/CREBBP/EP300/NOTCH1/E2F1/TP53",6
"R-HSA-2559585","R-HSA-2559585","Oncogene Induced Senescence","6/112","23/2914",0.000166710996009949,0.00099734122174373,0.000527995121250347,"MDM2/MAPK1/E2F1/MAPK3/TP53/SP1",6
"R-HSA-2029482","R-HSA-2029482","Regulation of actin dynamics for phagocytic cup formation","8/112","43/2914",0.000174599633776033,0.00103545174117612,0.000548170932587453,"CDC42/PAK1/HSP90AA1/GRB2/MAPK1/PTK2/ABL1/MAPK3",8
"R-HSA-422475","R-HSA-422475","Axon guidance","22/112","254/2914",0.000177338069855525,0.00104262554863334,0.000551968765521279,"CDC42/GSK3B/MAPK14/PAK1/HSP90AA1/PIK3CA/PIK3R1/GRB2/MAPK1/MAPK11/MAPK8/PTK2/SHC1/SRC/ABL1/EGFR/ERBB2/FGFR1/MAPK3/MET/RET/CREB1",22
"R-HSA-2559580","R-HSA-2559580","Oxidative Stress Induced Senescence","8/112","44/2914",0.000206646903336313,0.00120455716303731,0.000637695797070222,"MAPK14/MDM2/MAPK1/MAPK11/MAPK8/E2F1/MAPK3/TP53",8
"R-HSA-1839124","R-HSA-1839124","FGFR1 mutant receptor activation","6/112","24/2914",0.000215385184635672,0.00122410579934607,0.000648044897631889,"STAT1/PIK3CA/PIK3R1/GRB2/STAT3/FGFR1",6
"R-HSA-198725","R-HSA-198725","Nuclear Events (kinase and transcription factor activation)","6/112","24/2914",0.000215385184635672,0.00122410579934607,0.000648044897631889,"MAPK14/MAPK1/MAPK11/MAPK3/CREB1/MEF2A",6
"R-HSA-8941326","R-HSA-8941326","RUNX2 regulates bone development","6/112","24/2914",0.000215385184635672,0.00122410579934607,0.000648044897631889,"AR/MAPK1/SRC/ABL1/MAPK3/SMAD1",6
"R-HSA-6804756","R-HSA-6804756","Regulation of TP53 Activity through Phosphorylation","9/112","56/2914",0.00022027283473828,0.00124153779579758,0.000657273443368682,"MAPK14/MDM2/MAPK11/ATR/ATM/KAT5/TP53/CHEK2/NBN",9
"R-HSA-196299","R-HSA-196299","Beta-catenin phosphorylation cascade","5/112","16/2914",0.000238706305744999,0.00131288468159749,0.000695044676320327,"AMER1/APC/AXIN1/CTNNB1/GSK3B",5
"R-HSA-5668599","R-HSA-5668599","RHO GTPases Activate NADPH Oxidases","5/112","16/2914",0.000238706305744999,0.00131288468159749,0.000695044676320327,"MAPK14/PRKCD/MAPK1/MAPK11/MAPK3",5
"R-HSA-9034015","R-HSA-9034015","Signaling by NTRK3 (TRKC)","5/112","16/2914",0.000238706305744999,0.00131288468159749,0.000695044676320327,"PIK3CA/PIK3R1/GRB2/SHC1/SRC",5
"R-HSA-5218920","R-HSA-5218920","VEGFR2 mediated vascular permeability","6/112","25/2914",0.000274613277646349,0.0014863988520223,0.000786903544132812,"CTNNB1/PAK1/HSP90AA1/AKT1/AKT2/AKT3",6
"R-HSA-5663213","R-HSA-5663213","RHO GTPases Activate WASPs and WAVEs","6/112","25/2914",0.000274613277646349,0.0014863988520223,0.000786903544132812,"CDC42/GRB2/MAPK1/PTK2/ABL1/MAPK3",6
"R-HSA-373752","R-HSA-373752","Netrin-1 signaling","7/112","35/2914",0.000282899502148773,0.00151919260209026,0.000804264643489674,"CDC42/MAPK14/PAK1/MAPK11/MAPK8/PTK2/SRC",7
"R-HSA-112399","R-HSA-112399","IRS-mediated signalling","8/112","46/2914",0.00028529467409206,0.00152008568539676,0.000804737444190597,"PIK3CA/PIK3R1/AKT2/GRB2/FGF7/FGFR1/FGFR3/FGFR4",8
"R-HSA-3700989","R-HSA-3700989","Transcriptional Regulation by TP53","18/112","194/2914",0.000321835107757224,0.00170148483325912,0.000900770640234418,"CCNE1/CDK1/MAPK14/MDM2/CREBBP/AKT1/AKT2/AKT3/EP300/MAPK11/PML/ATR/E2F1/ATM/KAT5/TP53/CHEK2/NBN",18
"R-HSA-180292","R-HSA-180292","GAB1 signalosome","5/112","17/2914",0.000327875401623792,0.00170695438097272,0.000903666233483011,"PIK3CA/PIK3R1/GRB2/SRC/EGFR",5
"R-HSA-9013695","R-HSA-9013695","NOTCH4 Intracellular Domain Regulates Transcription","5/112","17/2914",0.000327875401623792,0.00170695438097272,0.000903666233483011,"KAT2B/SMAD3/CREBBP/EP300/NOTCH1",5
"R-HSA-6804759","R-HSA-6804759","Regulation of TP53 Activity through Association with Co-factors","4/112","10/2914",0.000363226156926217,0.00186255818814797,0.000986043306891114,"AKT1/AKT2/AKT3/TP53",4
"R-HSA-8853334","R-HSA-8853334","Signaling by FGFR3 fusions in cancer","4/112","10/2914",0.000363226156926217,0.00186255818814797,0.000986043306891114,"PIK3CA/PIK3R1/GRB2/FGFR3",4
"R-HSA-2454202","R-HSA-2454202","Fc epsilon receptor (FCERI) signaling","11/112","87/2914",0.000393770981962949,0.00200411798282635,0.00106098544236678,"MAP3K1/PAK1/PIK3CA/PIK3R1/GRB2/MAPK1/MAPK8/SHC1/MAPK3/RELA/NFATC1",11
"R-HSA-9012852","R-HSA-9012852","Signaling by NOTCH3","7/112","37/2914",0.000406384693374462,0.00205299526578802,0.00108686120723151,"KAT2B/STAT1/CREBBP/EP300/NOTCH1/EGFR/IKZF1",7
"R-HSA-881907","R-HSA-881907","Gastrin-CREB signalling pathway via PKC and MAPK","5/112","18/2914",0.000440174337327336,0.0022073448386562,0.00116857428562907,"GRB2/MAPK1/EGFR/MAPK3/CREB1",5
"R-HSA-186797","R-HSA-186797","Signaling by PDGF","8/112","49/2914",0.000447778346198883,0.00222908636574918,0.00118008430846113,"STAT1/PIK3CA/PIK3R1/GRB2/SRC/STAT3/PDGFRA/PDGFRB",8
"R-HSA-2428928","R-HSA-2428928","IRS-related events triggered by IGF1R","8/112","50/2914",0.00051622344947453,0.0025328373564146,0.00134089089867295,"PIK3CA/PIK3R1/AKT2/GRB2/FGF7/FGFR1/FGFR3/FGFR4",8
"R-HSA-5654738","R-HSA-5654738","Signaling by FGFR2","8/112","50/2914",0.00051622344947453,0.0025328373564146,0.00134089089867295,"PIK3CA/PIK3R1/GRB2/MAPK1/SHC1/SRC/FGF7/MAPK3",8
"R-HSA-5655291","R-HSA-5655291","Signaling by FGFR4 in disease","4/112","11/2914",0.000553940270082758,0.00269848045854601,0.00142858280179238,"PIK3CA/PIK3R1/GRB2/FGFR4",4
"R-HSA-1538133","R-HSA-1538133","G0 and Early G1","5/112","19/2914",0.000579224040617323,0.00274326941459038,0.00145229419540747,"CCNE1/CDK1/MYC/E2F1/MYBL2",5
"R-HSA-389513","R-HSA-389513","CTLA4 inhibitory signaling","5/112","19/2914",0.000579224040617323,0.00274326941459038,0.00145229419540747,"AKT1/AKT2/AKT3/SRC/LCK",5
"R-HSA-8940973","R-HSA-8940973","RUNX2 regulates osteoblast differentiation","5/112","19/2914",0.000579224040617323,0.00274326941459038,0.00145229419540747,"AR/MAPK1/SRC/ABL1/MAPK3",5
"R-HSA-9615017","R-HSA-9615017","FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes","5/112","19/2914",0.000579224040617323,0.00274326941459038,0.00145229419540747,"SMAD3/FOXO1/SMAD2/NR3C1/FOXO3",5
"R-HSA-453279","R-HSA-453279","Mitotic G1-G1/S phases","10/112","77/2914",0.00058913898016438,0.00277098472049729,0.0014669667527868,"CCNE1/CDK1/MYC/AKT1/AKT2/AKT3/SRC/ABL1/E2F1/MYBL2",10
"R-HSA-114452","R-HSA-114452","Activation of BH3-only proteins","6/112","29/2914",0.000649468570679238,0.0030131807156683,0.00159518596307181,"AKT1/AKT2/AKT3/MAPK8/E2F1/TP53",6
"R-HSA-1912422","R-HSA-1912422","Pre-NOTCH Expression and Processing","6/112","29/2914",0.000649468570679238,0.0030131807156683,0.00159518596307181,"KAT2B/CREBBP/EP300/NOTCH1/E2F1/TP53",6
"R-HSA-445144","R-HSA-445144","Signal transduction by L1","5/112","20/2914",0.000748843865204019,0.00345075348695366,0.00182683816333555,"PAK1/MAPK1/EGFR/FGFR1/MAPK3",5
"R-HSA-1433557","R-HSA-1433557","Signaling by SCF-KIT","7/112","41/2914",0.000781306765051894,0.00353177077030757,0.0018697289307231,"STAT1/PIK3CA/PIK3R1/GRB2/SRC/STAT3/LCK",7
"R-HSA-451927","R-HSA-451927","Interleukin-2 family signaling","7/112","41/2914",0.000781306765051894,0.00353177077030757,0.0018697289307231,"STAT1/PIK3CA/PIK3R1/GRB2/SHC1/STAT3/LCK",7
"R-HSA-69278","R-HSA-69278","Cell Cycle, Mitotic","17/112","191/2914",0.000781960977003581,0.00353177077030757,0.0018697289307231,"CCNE1/CDK1/GSK3B/HSP90AA1/MYC/AKT1/AKT2/AKT3/EP300/MAPK1/SRC/ABL1/E2F1/MAPK3/TP53/MYBL2/FOXM1",17
"R-HSA-5689880","R-HSA-5689880","Ub-specific processing proteases","10/112","80/2914",0.000802333731141038,0.00357127258429331,0.00189064129713321,"AR/AXIN1/MDM2/SMAD3/MYC/SMAD2/GATA3/TP53/SMAD1/HIF1A",10
"R-HSA-210744","R-HSA-210744","Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells","4/112","12/2914",0.000806416390001715,0.00357127258429331,0.00189064129713321,"KAT2B/CREBBP/EP300/NOTCH1",4
"R-HSA-389359","R-HSA-389359","CD28 dependent Vav1 pathway","4/112","12/2914",0.000806416390001715,0.00357127258429331,0.00189064129713321,"CDC42/PAK1/GRB2/LCK",4
"R-HSA-5693532","R-HSA-5693532","DNA Double-Strand Break Repair","10/112","81/2914",0.000886159115218629,0.00389910010696197,0.00206419406804747,"UBE2I/MAPK8/ABL1/ATR/ATM/KAT5/PRKDC/TP53/CHEK2/NBN",10
"R-HSA-4791275","R-HSA-4791275","Signaling by WNT in cancer","6/112","31/2914",0.000945370896224562,0.00410664300143408,0.00217406783375813,"AMER1/APC/AXIN1/CTNNB1/GSK3B/TCF7L2",6
"R-HSA-5655302","R-HSA-5655302","Signaling by FGFR1 in disease","6/112","31/2914",0.000945370896224562,0.00410664300143408,0.00217406783375813,"STAT1/PIK3CA/PIK3R1/GRB2/STAT3/FGFR1",6
"R-HSA-198753","R-HSA-198753","ERK/MAPK targets","5/112","21/2914",0.000953029443608961,0.00411370937051463,0.00217780878852681,"MAPK14/MAPK1/MAPK11/MAPK3/MEF2A",5
"R-HSA-3371453","R-HSA-3371453","Regulation of HSF1-mediated heat shock response","6/112","32/2914",0.0011275752163897,0.00456222936066822,0.00241525647585923,"GSK3B/MAPK1/ATR/MAPK3/ATM/SIRT1",6
"R-HSA-8853659","R-HSA-8853659","RET signaling","6/112","32/2914",0.0011275752163897,0.00456222936066822,0.00241525647585923,"PIK3CA/PIK3R1/GRB2/SHC1/SRC/RET",6
"R-HSA-4839735","R-HSA-4839735","AXIN mutants destabilize the destruction complex, activating WNT signaling","4/112","13/2914",0.00113052311136793,0.00456222936066822,0.00241525647585923,"AMER1/APC/AXIN1/GSK3B",4
"R-HSA-4839744","R-HSA-4839744","truncated APC mutants destabilize the destruction complex","4/112","13/2914",0.00113052311136793,0.00456222936066822,0.00241525647585923,"AMER1/APC/AXIN1/GSK3B",4
"R-HSA-4839748","R-HSA-4839748","AMER1 mutants destabilize the destruction complex","4/112","13/2914",0.00113052311136793,0.00456222936066822,0.00241525647585923,"AMER1/APC/AXIN1/GSK3B",4
"R-HSA-5467337","R-HSA-5467337","APC truncation mutants have impaired AXIN binding","4/112","13/2914",0.00113052311136793,0.00456222936066822,0.00241525647585923,"AMER1/APC/AXIN1/GSK3B",4
"R-HSA-5467340","R-HSA-5467340","AXIN missense mutants destabilize the destruction complex","4/112","13/2914",0.00113052311136793,0.00456222936066822,0.00241525647585923,"AMER1/APC/AXIN1/GSK3B",4
"R-HSA-5467348","R-HSA-5467348","Truncations of AMER1 destabilize the destruction complex","4/112","13/2914",0.00113052311136793,0.00456222936066822,0.00241525647585923,"AMER1/APC/AXIN1/GSK3B",4
"R-HSA-8847993","R-HSA-8847993","ERBB2 Activates PTK6 Signaling","4/112","13/2914",0.00113052311136793,0.00456222936066822,0.00241525647585923,"ERBB4/EGFR/ERBB2/ERBB3",4
"R-HSA-8941856","R-HSA-8941856","RUNX3 regulates NOTCH signaling","4/112","13/2914",0.00113052311136793,0.00456222936066822,0.00241525647585923,"KAT2B/CREBBP/EP300/NOTCH1",4
"R-HSA-9614657","R-HSA-9614657","FOXO-mediated transcription of cell death genes","4/112","13/2914",0.00113052311136793,0.00456222936066822,0.00241525647585923,"CREBBP/FOXO1/EP300/FOXO3",4
"R-HSA-195258","R-HSA-195258","RHO GTPase Effectors","13/112","130/2914",0.00117154088301069,0.00469994636596055,0.00248816422831373,"AR/CDC42/CTNNB1/MAPK14/PAK1/PRKCD/GRB2/MAPK1/MAPK11/PTK2/SRC/ABL1/MAPK3",13
"R-HSA-69563","R-HSA-69563","p53-Dependent G1 DNA Damage Response","5/112","22/2914",0.00119592978012427,0.00474200063979507,0.00251042787382267,"CCNE1/MDM2/ATM/TP53/CHEK2",5
"R-HSA-69580","R-HSA-69580","p53-Dependent G1/S DNA damage checkpoint","5/112","22/2914",0.00119592978012427,0.00474200063979507,0.00251042787382267,"CCNE1/MDM2/ATM/TP53/CHEK2",5
"R-HSA-177929","R-HSA-177929","Signaling by EGFR","7/112","44/2914",0.00121058020953046,0.00477234510346688,0.00252649231438361,"CDC42/PIK3CA/PIK3R1/GRB2/SHC1/SRC/EGFR",7
"R-HSA-597592","R-HSA-597592","Post-translational protein modification","27/112","393/2914",0.001379000258905,0.00540504699180004,0.00286144639325114,"APC/AR/AXIN1/CDK1/ESR1/KAT2B/MDM2/PIAS1/SMAD3/UBE2I/CDC73/CREBBP/MYC/SMAD2/EP300/GATA3/PML/PPARG/PRKDC/TP53/NCOR2/NR1I2/RELA/NR3C1/TDG/SMAD1/HIF1A",27
"R-HSA-8878171","R-HSA-8878171","Transcriptional regulation by RUNX1","10/112","86/2914",0.00142072737766138,0.00553677755180035,0.00293118490549085,"AXIN1/ESR1/KAT2B/CREBBP/EP300/GATA3/PML/SRC/ABL1/KMT2A",10
"R-HSA-5685938","R-HSA-5685938","HDR through Single Strand Annealing (SSA)","5/112","23/2914",0.0014818238868227,0.00574206756143796,0.00303986598791977,"ABL1/ATR/ATM/KAT5/NBN",5
"R-HSA-1295596","R-HSA-1295596","Spry regulation of FGF signaling","4/112","14/2914",0.00153617602229816,0.0058529164648455,0.0030985496950795,"GRB2/MAPK1/SRC/MAPK3",4
"R-HSA-6785631","R-HSA-6785631","ERBB2 Regulates Cell Motility","4/112","14/2914",0.00153617602229816,0.0058529164648455,0.0030985496950795,"ERBB4/EGFR/ERBB2/ERBB3",4
"R-HSA-9617828","R-HSA-9617828","FOXO-mediated transcription of cell cycle genes","4/112","14/2914",0.00153617602229816,0.0058529164648455,0.0030985496950795,"SMAD3/FOXO1/SMAD2/FOXO3",4
"R-HSA-5687128","R-HSA-5687128","MAPK6/MAPK4 signaling","6/112","34/2914",0.00157170578014044,0.00595501856697655,0.00315260282215304,"CDC42/CDK1/PAK1/FOXO1/MYC/FOXO3",6
"R-HSA-69473","R-HSA-69473","G2/M DNA damage checkpoint","7/112","46/2914",0.00158680534647418,0.00597901241047177,0.00316530522733727,"CDK1/ATR/ATM/KAT5/TP53/CHEK2/NBN",7
"R-HSA-6807070","R-HSA-6807070","PTEN Regulation","8/112","59/2914",0.00159756311652129,0.00598647277729408,0.00316925476556856,"AKT1/AKT2/AKT3/MAPK1/PML/PPARG/MAPK3/TP53",8
"R-HSA-556833","R-HSA-556833","Metabolism of lipids","12/112","119/2914",0.00169724085551533,0.00632523641235768,0.00334859714375472,"UBE2I/CREBBP/PIK3CA/PIK3R1/EP300/PIK3CG/PPARG/PPP1CA/NCOR1/NCOR2/ARNT/SP1",12
"R-HSA-1989781","R-HSA-1989781","PPARA activates gene expression","7/112","47/2914",0.00180623106051308,0.00651524373958622,0.00344918753307312,"CREBBP/EP300/PPARG/NCOR1/NCOR2/ARNT/SP1",7
"R-HSA-76002","R-HSA-76002","Platelet activation, signaling and aggregation","14/112","153/2914",0.00180657231291694,0.00651524373958622,0.00344918753307312,"CDC42/MAPK14/PIK3CA/PIK3R1/PRKCD/AKT1/GRB2/MAPK1/PIK3CG/PTK2/SHC1/SRC/MAPK3/LCK",14
"R-HSA-2172127","R-HSA-2172127","DAP12 interactions","5/112","24/2914",0.00181509722950349,0.00651524373958622,0.00344918753307312,"PIK3CA/PIK3R1/GRB2/SHC1/LCK",5
"R-HSA-2424491","R-HSA-2424491","DAP12 signaling","5/112","24/2914",0.00181509722950349,0.00651524373958622,0.00344918753307312,"PIK3CA/PIK3R1/GRB2/SHC1/LCK",5
"R-HSA-2559586","R-HSA-2559586","DNA Damage/Telomere Stress Induced Senescence","5/112","24/2914",0.00181509722950349,0.00651524373958622,0.00344918753307312,"CCNE1/ATM/KAT5/TP53/NBN",5
"R-HSA-69615","R-HSA-69615","G1/S DNA Damage Checkpoints","5/112","24/2914",0.00181509722950349,0.00651524373958622,0.00344918753307312,"CCNE1/MDM2/ATM/TP53/CHEK2",5
"R-HSA-9006335","R-HSA-9006335","Signaling by Erythropoietin","5/112","24/2914",0.00181509722950349,0.00651524373958622,0.00344918753307312,"PIK3CA/PIK3R1/GRB2/PIK3CG/SHC1",5
"R-HSA-2730905","R-HSA-2730905","Role of LAT2/NTAL/LAB on calcium mobilization","4/112","15/2914",0.00203323436030571,0.00718479706595074,0.00380365086220266,"PIK3CA/PIK3R1/GRB2/SHC1",4
"R-HSA-69541","R-HSA-69541","Stabilization of p53","4/112","15/2914",0.00203323436030571,0.00718479706595074,0.00380365086220266,"MDM2/ATM/TP53/CHEK2",4
"R-HSA-8876384","R-HSA-8876384","Listeria monocytogenes entry into host cells","4/112","15/2914",0.00203323436030571,0.00718479706595074,0.00380365086220266,"CTNNB1/GRB2/SRC/MET",4
"R-HSA-400206","R-HSA-400206","Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)","7/112","48/2914",0.00204855565954364,0.00720162350416888,0.00381255882378442,"CREBBP/EP300/PPARG/NCOR1/NCOR2/ARNT/SP1",7
"R-HSA-2173793","R-HSA-2173793","Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer","6/112","36/2914",0.00213799266505168,0.00747749229520639,0.0039586045026328,"SMAD3/MYC/SMAD2/NCOR1/NCOR2/SP1",6
"R-HSA-354192","R-HSA-354192","Integrin alphaIIb beta3 signaling","5/112","25/2914",0.00220021821746778,0.00754044635333178,0.00399193255007378,"AKT1/GRB2/PTK2/SHC1/SRC",5
"R-HSA-5654708","R-HSA-5654708","Downstream signaling of activated FGFR3","5/112","25/2914",0.00220021821746778,0.00754044635333178,0.00399193255007378,"PIK3CA/PIK3R1/GRB2/SHC1/FGFR3",5
"R-HSA-9006115","R-HSA-9006115","Signaling by NTRK2 (TRKB)","5/112","25/2914",0.00220021821746778,0.00754044635333178,0.00399193255007378,"PIK3CA/PIK3R1/GRB2/SHC1/SRC",5
"R-HSA-9006921","R-HSA-9006921","Integrin signaling","5/112","25/2914",0.00220021821746778,0.00754044635333178,0.00399193255007378,"AKT1/GRB2/PTK2/SHC1/SRC",5
"R-HSA-6806834","R-HSA-6806834","Signaling by MET","8/112","62/2914",0.00221276841803753,0.00754554030550799,0.00399462930203618,"PIK3CA/PIK3R1/GRB2/PTK2/SHC1/SRC/STAT3/MET",8
"R-HSA-168142","R-HSA-168142","Toll Like Receptor 10 (TLR10) Cascade","9/112","78/2914",0.00260729216038339,0.00862033296498866,0.00456362742242801,"MAP3K1/MAPK14/MAPK1/MAPK11/MAPK8/MAPK3/RELA/CREB1/MEF2A",9
"R-HSA-168176","R-HSA-168176","Toll Like Receptor 5 (TLR5) Cascade","9/112","78/2914",0.00260729216038339,0.00862033296498866,0.00456362742242801,"MAP3K1/MAPK14/MAPK1/MAPK11/MAPK8/MAPK3/RELA/CREB1/MEF2A",9
"R-HSA-975871","R-HSA-975871","MyD88 cascade initiated on plasma membrane","9/112","78/2914",0.00260729216038339,0.00862033296498866,0.00456362742242801,"MAP3K1/MAPK14/MAPK1/MAPK11/MAPK8/MAPK3/RELA/CREB1/MEF2A",9
"R-HSA-1963640","R-HSA-1963640","GRB2 events in ERBB2 signaling","4/112","16/2914",0.00263141037849261,0.00862033296498866,0.00456362742242801,"ERBB4/GRB2/EGFR/ERBB2",4
"R-HSA-3232118","R-HSA-3232118","SUMOylation of transcription factors","4/112","16/2914",0.00263141037849261,0.00862033296498866,0.00456362742242801,"MDM2/PIAS1/UBE2I/TP53",4
"R-HSA-392451","R-HSA-392451","G beta:gamma signalling through PI3Kgamma","4/112","16/2914",0.00263141037849261,0.00862033296498866,0.00456362742242801,"AKT1/AKT2/AKT3/PIK3CG",4
"R-HSA-350054","R-HSA-350054","Notch-HLH transcription pathway","5/112","26/2914",0.00264171494088362,0.00862033296498866,0.00456362742242801,"KAT2B/CREBBP/NOTCH1/NCOR1/NCOR2",5
"R-HSA-5654716","R-HSA-5654716","Downstream signaling of activated FGFR4","5/112","26/2914",0.00264171494088362,0.00862033296498866,0.00456362742242801,"PIK3CA/PIK3R1/GRB2/SHC1/FGFR4",5
"R-HSA-8939902","R-HSA-8939902","Regulation of RUNX2 expression and activity","5/112","26/2914",0.00264171494088362,0.00862033296498866,0.00456362742242801,"ESR1/GSK3B/STAT1/NR3C1/TWIST1",5
"R-HSA-1980143","R-HSA-1980143","Signaling by NOTCH1","8/112","64/2914",0.0027171311830445,0.00882420698493501,0.0046715588761116,"KAT2B/CREBBP/MYC/EP300/NOTCH1/NCOR1/NCOR2/HIF1A",8
"R-HSA-2644602","R-HSA-2644602","Signaling by NOTCH1 PEST Domain Mutants in Cancer","7/112","51/2914",0.00292885115061099,0.00929058830100789,0.00491846239735408,"KAT2B/CREBBP/MYC/EP300/NOTCH1/NCOR1/NCOR2",7
"R-HSA-2644603","R-HSA-2644603","Signaling by NOTCH1 in Cancer","7/112","51/2914",0.00292885115061099,0.00929058830100789,0.00491846239735408,"KAT2B/CREBBP/MYC/EP300/NOTCH1/NCOR1/NCOR2",7
"R-HSA-2644606","R-HSA-2644606","Constitutive Signaling by NOTCH1 PEST Domain Mutants","7/112","51/2914",0.00292885115061099,0.00929058830100789,0.00491846239735408,"KAT2B/CREBBP/MYC/EP300/NOTCH1/NCOR1/NCOR2",7
"R-HSA-2894858","R-HSA-2894858","Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer","7/112","51/2914",0.00292885115061099,0.00929058830100789,0.00491846239735408,"KAT2B/CREBBP/MYC/EP300/NOTCH1/NCOR1/NCOR2",7
"R-HSA-2894862","R-HSA-2894862","Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants","7/112","51/2914",0.00292885115061099,0.00929058830100789,0.00491846239735408,"KAT2B/CREBBP/MYC/EP300/NOTCH1/NCOR1/NCOR2",7
"R-HSA-5654732","R-HSA-5654732","Negative regulation of FGFR3 signaling","5/112","27/2914",0.00314415233202103,0.00992736986314047,0.00525557626648739,"GRB2/MAPK1/SRC/FGFR3/MAPK3",5
"R-HSA-69202","R-HSA-69202","Cyclin E associated events during G1/S transition ","6/112","39/2914",0.00326033223713358,0.0102467584595627,0.0054246614471832,"CCNE1/MYC/AKT1/AKT2/AKT3/E2F1",6
"R-HSA-210993","R-HSA-210993","Tie2 Signaling","4/112","17/2914",0.00334019037137533,0.0104018713848309,0.00550677864639143,"PIK3CA/PIK3R1/GRB2/SHC1",4
"R-HSA-3232142","R-HSA-3232142","SUMOylation of ubiquitinylation proteins","4/112","17/2914",0.00334019037137533,0.0104018713848309,0.00550677864639143,"MDM2/PIAS1/UBE2I/PML",4
"R-HSA-114604","R-HSA-114604","GPVI-mediated activation cascade","5/112","28/2914",0.00371210990161748,0.0113189191248342,0.00599226618277225,"CDC42/PIK3CA/PIK3R1/PIK3CG/LCK",5
"R-HSA-5654687","R-HSA-5654687","Downstream signaling of activated FGFR1","5/112","28/2914",0.00371210990161748,0.0113189191248342,0.00599226618277225,"PIK3CA/PIK3R1/GRB2/SHC1/FGFR1",5
"R-HSA-5654733","R-HSA-5654733","Negative regulation of FGFR4 signaling","5/112","28/2914",0.00371210990161748,0.0113189191248342,0.00599226618277225,"GRB2/MAPK1/SRC/FGFR4/MAPK3",5
"R-HSA-69656","R-HSA-69656","Cyclin A:Cdk2-associated events at S phase entry","6/112","40/2914",0.00371765085625054,0.0113189191248342,0.00599226618277225,"CCNE1/MYC/AKT1/AKT2/AKT3/E2F1",6
"R-HSA-9013694","R-HSA-9013694","Signaling by NOTCH4","6/112","40/2914",0.00371765085625054,0.0113189191248342,0.00599226618277225,"KAT2B/SMAD3/CREBBP/AKT1/EP300/NOTCH1",6
"R-HSA-975138","R-HSA-975138","TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation","9/112","83/2914",0.00400084501875114,0.0121270057901701,0.00642006943359831,"MAP3K1/MAPK14/MAPK1/MAPK11/MAPK8/MAPK3/RELA/CREB1/MEF2A",9
"R-HSA-5654710","R-HSA-5654710","PI-3K cascade:FGFR3","4/112","18/2914",0.00416876638110332,0.0125800826190817,0.00665992952360707,"PIK3CA/PIK3R1/GRB2/FGFR3",4
"R-HSA-168181","R-HSA-168181","Toll Like Receptor 7/8 (TLR7/8) Cascade","9/112","84/2914",0.00433911387627188,0.0129792792263922,0.00687126527959951,"MAP3K1/MAPK14/MAPK1/MAPK11/MAPK8/MAPK3/RELA/CREB1/MEF2A",9
"R-HSA-975155","R-HSA-975155","MyD88 dependent cascade initiated on endosome","9/112","84/2914",0.00433911387627188,0.0129792792263922,0.00687126527959951,"MAP3K1/MAPK14/MAPK1/MAPK11/MAPK8/MAPK3/RELA/CREB1/MEF2A",9
"R-HSA-4641262","R-HSA-4641262","Disassembly of the destruction complex and recruitment of AXIN to the membrane","5/112","30/2914",0.00506284796313385,0.0147503595689214,0.0078088799693472,"AMER1/APC/AXIN1/CTNNB1/GSK3B",5
"R-HSA-5654696","R-HSA-5654696","Downstream signaling of activated FGFR2","5/112","30/2914",0.00506284796313385,0.0147503595689214,0.0078088799693472,"PIK3CA/PIK3R1/GRB2/SHC1/FGF7",5
"R-HSA-5654726","R-HSA-5654726","Negative regulation of FGFR1 signaling","5/112","30/2914",0.00506284796313385,0.0147503595689214,0.0078088799693472,"GRB2/MAPK1/SRC/FGFR1/MAPK3",5
"R-HSA-6791312","R-HSA-6791312","TP53 Regulates Transcription of Cell Cycle Genes","5/112","30/2914",0.00506284796313385,0.0147503595689214,0.0078088799693472,"CCNE1/CDK1/EP300/E2F1/TP53",5
"R-HSA-166058","R-HSA-166058","MyD88:MAL(TIRAP) cascade initiated on plasma membrane","9/112","86/2914",0.00508260190424712,0.0147503595689214,0.0078088799693472,"MAP3K1/MAPK14/MAPK1/MAPK11/MAPK8/MAPK3/RELA/CREB1/MEF2A",9
"R-HSA-168138","R-HSA-168138","Toll Like Receptor 9 (TLR9) Cascade","9/112","86/2914",0.00508260190424712,0.0147503595689214,0.0078088799693472,"MAP3K1/MAPK14/MAPK1/MAPK11/MAPK8/MAPK3/RELA/CREB1/MEF2A",9
"R-HSA-168188","R-HSA-168188","Toll Like Receptor TLR6:TLR2 Cascade","9/112","86/2914",0.00508260190424712,0.0147503595689214,0.0078088799693472,"MAP3K1/MAPK14/MAPK1/MAPK11/MAPK8/MAPK3/RELA/CREB1/MEF2A",9
"R-HSA-5621575","R-HSA-5621575","CD209 (DC-SIGN) signaling","4/112","19/2914",0.00512597767189958,0.0147507036803186,0.00780906214284503,"PAK1/CREBBP/EP300/RELA",4
"R-HSA-5654720","R-HSA-5654720","PI-3K cascade:FGFR4","4/112","19/2914",0.00512597767189958,0.0147507036803186,0.00780906214284503,"PIK3CA/PIK3R1/GRB2/FGFR4",4
"R-HSA-1250342","R-HSA-1250342","PI3K events in ERBB4 signaling","3/112","10/2914",0.00544427005239958,0.0154708007322355,0.00819028345602218,"PIK3CA/PIK3R1/ERBB4",3
"R-HSA-1362300","R-HSA-1362300","Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1","3/112","10/2914",0.00544427005239958,0.0154708007322355,0.00819028345602218,"CDK1/E2F1/MYBL2",3
"R-HSA-5250924","R-HSA-5250924","B-WICH complex positively regulates rRNA expression","3/112","10/2914",0.00544427005239958,0.0154708007322355,0.00819028345602218,"GSK3B/KAT2B/EP300",3
"R-HSA-168179","R-HSA-168179","Toll Like Receptor TLR1:TLR2 Cascade","9/112","87/2914",0.00548973693110544,0.0154710768058426,0.00819042961013122,"MAP3K1/MAPK14/MAPK1/MAPK11/MAPK8/MAPK3/RELA/CREB1/MEF2A",9
"R-HSA-181438","R-HSA-181438","Toll Like Receptor 2 (TLR2) Cascade","9/112","87/2914",0.00548973693110544,0.0154710768058426,0.00819042961013122,"MAP3K1/MAPK14/MAPK1/MAPK11/MAPK8/MAPK3/RELA/CREB1/MEF2A",9
"R-HSA-1500931","R-HSA-1500931","Cell-Cell communication","7/112","57/2914",0.00553146122020802,0.0155245125604192,0.00821871864211111,"CTNNB1/PIK3CA/PIK3R1/GRB2/ITGB4/PTK2/SRC",7
"R-HSA-2173795","R-HSA-2173795","Downregulation of SMAD2/3:SMAD4 transcriptional activity","4/112","20/2914",0.00622026112357347,0.017386139697857,0.00920426904825583,"SMAD3/SMAD2/NCOR1/NCOR2",4
"R-HSA-73894","R-HSA-73894","DNA Repair","13/112","157/2914",0.00630857898514171,0.0175610239504761,0.00929685324126147,"PIAS1/UBE2I/EP300/MAPK8/ABL1/ATR/ATM/KAT5/PRKDC/TP53/CHEK2/NBN/TDG",13
"R-HSA-5654727","R-HSA-5654727","Negative regulation of FGFR2 signaling","5/112","32/2914",0.00673005848704016,0.0186581296266723,0.00987766393262633,"GRB2/MAPK1/SRC/FGF7/MAPK3",5
"R-HSA-3371568","R-HSA-3371568","Attenuation phase","3/112","11/2914",0.0072781437207684,0.0197756733767492,0.0104692945951921,"CREBBP/HSP90AA1/EP300",3
"R-HSA-418885","R-HSA-418885","DCC mediated attractive signaling","3/112","11/2914",0.0072781437207684,0.0197756733767492,0.0104692945951921,"CDC42/PTK2/SRC",3
"R-HSA-6804116","R-HSA-6804116","TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest","3/112","11/2914",0.0072781437207684,0.0197756733767492,0.0104692945951921,"CCNE1/E2F1/TP53",3
"R-HSA-8866910","R-HSA-8866910","TFAP2 (AP-2) family regulates transcription of growth factors and their receptors","3/112","11/2914",0.0072781437207684,0.0197756733767492,0.0104692945951921,"ESR1/EGFR/ERBB2",3
"R-HSA-9027276","R-HSA-9027276","Erythropoietin activates Phosphoinositide-3-kinase (PI3K)","3/112","11/2914",0.0072781437207684,0.0197756733767492,0.0104692945951921,"PIK3CA/PIK3R1/PIK3CG",3
"R-HSA-450294","R-HSA-450294","MAP kinase activation","7/112","60/2914",0.0073495602807999,0.0198118581482432,0.0104884509103989,"MAPK14/MAPK1/MAPK11/MAPK8/MAPK3/CREB1/MEF2A",7
"R-HSA-69206","R-HSA-69206","G1/S Transition","7/112","60/2914",0.0073495602807999,0.0198118581482432,0.0104884509103989,"CCNE1/CDK1/MYC/AKT1/AKT2/AKT3/E2F1",7
"R-HSA-111465","R-HSA-111465","Apoptotic cleavage of cellular proteins","4/112","21/2914",0.00745960975415336,0.0199507994209121,0.0105620067932904,"APC/CTNNB1/PRKCD/PTK2",4
"R-HSA-5654689","R-HSA-5654689","PI-3K cascade:FGFR1","4/112","21/2914",0.00745960975415336,0.0199507994209121,0.0105620067932904,"PIK3CA/PIK3R1/GRB2/FGFR1",4
"R-HSA-76009","R-HSA-76009","Platelet Aggregation (Plug Formation)","5/112","33/2914",0.00769335846944667,0.0204955877975103,0.0108504192229449,"AKT1/GRB2/PTK2/SHC1/SRC",5
"R-HSA-1834949","R-HSA-1834949","Cytosolic sensors of pathogen-associated DNA ","5/112","34/2914",0.00874881582967187,0.0231293078567769,0.0122447176954383,"CTNNB1/CREBBP/EP300/PRKDC/RELA",5
"R-HSA-69481","R-HSA-69481","G2/M Checkpoints","7/112","62/2914",0.00878652308102616,0.0231293078567769,0.0122447176954383,"CDK1/ATR/ATM/KAT5/TP53/CHEK2/NBN",7
"R-HSA-1500620","R-HSA-1500620","Meiosis","4/112","22/2914",0.00885153863727095,0.0231293078567769,0.0122447176954383,"UBE2I/ATR/ATM/NBN",4
"R-HSA-5655332","R-HSA-5655332","Signaling by FGFR3 in disease","4/112","22/2914",0.00885153863727095,0.0231293078567769,0.0122447176954383,"PIK3CA/PIK3R1/GRB2/FGFR3",4
"R-HSA-8853338","R-HSA-8853338","Signaling by FGFR3 point mutants in cancer","4/112","22/2914",0.00885153863727095,0.0231293078567769,0.0122447176954383,"PIK3CA/PIK3R1/GRB2/FGFR3",4
"R-HSA-170968","R-HSA-170968","Frs2-mediated activation","3/112","12/2914",0.0094353861643573,0.0245608143667621,0.0130025610862778,"MAPK1/MAPK3/NTRK1",3
"R-HSA-168249","R-HSA-168249","Innate Immune System","26/112","428/2914",0.00951643403375357,0.0246775970000758,0.0130643861259855,"CDC42/CTNNB1/MAP3K1/MAPK14/PAK1/CREBBP/HSP90AA1/PIK3CA/PIK3R1/PRKCD/EP300/GRB2/MAPK1/MAPK11/MAPK8/PTK2/SHC1/SRC/ABL1/MAPK3/PRKDC/RELA/LCK/NFATC1/CREB1/MEF2A",26
"R-HSA-170834","R-HSA-170834","Signaling by TGF-beta Receptor Complex","7/112","63/2914",0.0095779897736642,0.0247431402486325,0.0130990848977943,"SMAD3/MYC/SMAD2/PPP1CA/NCOR1/NCOR2/SP1",7
"R-HSA-5654695","R-HSA-5654695","PI-3K cascade:FGFR2","4/112","23/2914",0.0104030575321021,0.0266172884797319,0.0140912640045502,"PIK3CA/PIK3R1/GRB2/FGF7",4
"R-HSA-5693616","R-HSA-5693616","Presynaptic phase of homologous DNA pairing and strand exchange","4/112","23/2914",0.0104030575321021,0.0266172884797319,0.0140912640045502,"ATR/ATM/KAT5/NBN",4
"R-HSA-448424","R-HSA-448424","Interleukin-17 signaling","7/112","64/2914",0.0104205513549684,0.0266172884797319,0.0140912640045502,"MAPK14/MAPK1/MAPK11/MAPK8/MAPK3/CREB1/MEF2A",7
"R-HSA-169893","R-HSA-169893","Prolonged ERK activation events","3/112","13/2914",0.0119268450802541,0.029950300804957,0.015855769680661,"MAPK1/MAPK3/NTRK1",3
"R-HSA-171007","R-HSA-171007","p38MAPK events","3/112","13/2914",0.0119268450802541,0.029950300804957,0.015855769680661,"MAPK14/MAPK11/SRC",3
"R-HSA-354194","R-HSA-354194","GRB2:SOS provides linkage to MAPK signaling for Integrins ","3/112","13/2914",0.0119268450802541,0.029950300804957,0.015855769680661,"GRB2/PTK2/SRC",3
"R-HSA-8876198","R-HSA-8876198","RAB GEFs exchange GTP for GDP on RABs","3/112","13/2914",0.0119268450802541,0.029950300804957,0.015855769680661,"AKT1/AKT2/AKT3",3
"R-HSA-1234174","R-HSA-1234174","Cellular response to hypoxia","4/112","24/2914",0.0121206495926219,0.029950300804957,0.015855769680661,"CREBBP/EP300/ARNT/HIF1A",4
"R-HSA-1474165","R-HSA-1474165","Reproduction","4/112","24/2914",0.0121206495926219,0.029950300804957,0.015855769680661,"UBE2I/ATR/ATM/NBN",4
"R-HSA-2173796","R-HSA-2173796","SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription","4/112","24/2914",0.0121206495926219,0.029950300804957,0.015855769680661,"SMAD3/MYC/SMAD2/SP1",4
"R-HSA-5693579","R-HSA-5693579","Homologous DNA Pairing and Strand Exchange","4/112","24/2914",0.0121206495926219,0.029950300804957,0.015855769680661,"ATR/ATM/KAT5/NBN",4
"R-HSA-982772","R-HSA-982772","Growth hormone receptor signaling","4/112","24/2914",0.0121206495926219,0.029950300804957,0.015855769680661,"STAT1/MAPK1/STAT3/MAPK3",4
"R-HSA-212165","R-HSA-212165","Epigenetic regulation of gene expression","5/112","37/2914",0.0125087491585232,0.030686931388895,0.0162457438900926,"GSK3B/KAT2B/EP300/SIRT1/TDG",5
"R-HSA-3899300","R-HSA-3899300","SUMOylation of transcription cofactors","5/112","37/2914",0.0125087491585232,0.030686931388895,0.0162457438900926,"PIAS1/UBE2I/CREBBP/EP300/NCOR2",5
"R-HSA-1592230","R-HSA-1592230","Mitochondrial biogenesis","5/112","38/2914",0.0139727441754711,0.034033612598826,0.0180174859104759,"MAPK14/CREBBP/MAPK11/NCOR1/CREB1",5
"R-HSA-373755","R-HSA-373755","Semaphorin interactions","5/112","38/2914",0.0139727441754711,0.034033612598826,0.0180174859104759,"GSK3B/PAK1/HSP90AA1/ERBB2/MET",5
"R-HSA-453274","R-HSA-453274","Mitotic G2-G2/M phases","7/112","68/2914",0.0143377542040297,0.0347983927656521,0.018422362584687,"CDK1/HSP90AA1/EP300/E2F1/TP53/MYBL2/FOXM1",7
"R-HSA-1250347","R-HSA-1250347","SHC1 events in ERBB4 signaling","3/112","14/2914",0.0147606639142421,0.0353220097877653,0.0186995668424194,"ERBB4/GRB2/SHC1",3
"R-HSA-180336","R-HSA-180336","SHC1 events in EGFR signaling","3/112","14/2914",0.0147606639142421,0.0353220097877653,0.0186995668424194,"GRB2/SHC1/EGFR",3
"R-HSA-5693554","R-HSA-5693554","Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)","3/112","14/2914",0.0147606639142421,0.0353220097877653,0.0186995668424194,"ATM/KAT5/NBN",3
"R-HSA-8983432","R-HSA-8983432","Interleukin-15 signaling","3/112","14/2914",0.0147606639142421,0.0353220097877653,0.0186995668424194,"GRB2/SHC1/STAT3",3
"R-HSA-373760","R-HSA-373760","L1CAM interactions","6/112","53/2914",0.0148359684115237,0.0353780785197873,0.01872924977973,"PAK1/MAPK1/SRC/EGFR/FGFR1/MAPK3",6
"R-HSA-75153","R-HSA-75153","Apoptotic execution phase","4/112","26/2914",0.0160772629557432,0.0380718518604751,0.0201553406206868,"APC/CTNNB1/PRKCD/PTK2",4
"R-HSA-912526","R-HSA-912526","Interleukin receptor SHC signaling","4/112","26/2914",0.0160772629557432,0.0380718518604751,0.0201553406206868,"PIK3CA/PIK3R1/GRB2/SHC1",4
"R-HSA-9006936","R-HSA-9006936","Signaling by TGF-beta family members","8/112","86/2914",0.0161535428268945,0.0381201252869967,0.0201808967023304,"SMAD3/MYC/SMAD2/PPP1CA/NCOR1/NCOR2/SMAD1/SP1",8
"R-HSA-168164","R-HSA-168164","Toll Like Receptor 3 (TLR3) Cascade","8/112","87/2914",0.017233421904949,0.0403854769916147,0.0213801799785829,"MAPK14/MAPK1/MAPK11/MAPK8/MAPK3/RELA/CREB1/MEF2A",8
"R-HSA-4086398","R-HSA-4086398","Ca2+ pathway","5/112","40/2914",0.0172381628745761,0.0403854769916147,0.0213801799785829,"CTNNB1/NFATC1/LEF1/TCF7/TCF7L2",5
"R-HSA-69242","R-HSA-69242","S Phase","7/112","71/2914",0.0178989827566907,0.0403854769916147,0.0213801799785829,"CCNE1/GSK3B/MYC/AKT1/AKT2/AKT3/E2F1",7
"R-HSA-111447","R-HSA-111447","Activation of BAD and translocation to mitochondria ","3/112","15/2914",0.0179425213027262,0.0403854769916147,0.0213801799785829,"AKT1/AKT2/AKT3",3
"R-HSA-1181150","R-HSA-1181150","Signaling by NODAL","3/112","15/2914",0.0179425213027262,0.0403854769916147,0.0213801799785829,"SMAD3/SMAD2/FOXO3",3
"R-HSA-1433559","R-HSA-1433559","Regulation of KIT signaling","3/112","15/2914",0.0179425213027262,0.0403854769916147,0.0213801799785829,"GRB2/SRC/LCK",3
"R-HSA-1660499","R-HSA-1660499","Synthesis of PIPs at the plasma membrane","3/112","15/2914",0.0179425213027262,0.0403854769916147,0.0213801799785829,"PIK3CA/PIK3R1/PIK3CG",3
"R-HSA-3371497","R-HSA-3371497","HSP90 chaperone cycle for steroid hormone receptors (SHR)","3/112","15/2914",0.0179425213027262,0.0403854769916147,0.0213801799785829,"AR/HSP90AA1/NR3C1",3
"R-HSA-5250913","R-HSA-5250913","Positive epigenetic regulation of rRNA expression","3/112","15/2914",0.0179425213027262,0.0403854769916147,0.0213801799785829,"GSK3B/KAT2B/EP300",3
"R-HSA-5693537","R-HSA-5693537","Resolution of D-Loop Structures","3/112","15/2914",0.0179425213027262,0.0403854769916147,0.0213801799785829,"ATM/KAT5/NBN",3
"R-HSA-5693568","R-HSA-5693568","Resolution of D-loop Structures through Holliday Junction Intermediates","3/112","15/2914",0.0179425213027262,0.0403854769916147,0.0213801799785829,"ATM/KAT5/NBN",3
"R-HSA-6803204","R-HSA-6803204","TP53 Regulates Transcription of Genes Involved in Cytochrome C Release","3/112","15/2914",0.0179425213027262,0.0403854769916147,0.0213801799785829,"CREBBP/ATM/TP53",3
"R-HSA-6804114","R-HSA-6804114","TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest","3/112","15/2914",0.0179425213027262,0.0403854769916147,0.0213801799785829,"CDK1/EP300/TP53",3
"R-HSA-69205","R-HSA-69205","G1/S-Specific Transcription","3/112","15/2914",0.0179425213027262,0.0403854769916147,0.0213801799785829,"CCNE1/CDK1/E2F1",3
"R-HSA-1251985","R-HSA-1251985","Nuclear signaling by ERBB4","4/112","27/2914",0.0183264995859557,0.0408453356785027,0.0216236304024177,"ESR1/ERBB4/SRC/NCOR1",4
"R-HSA-5689896","R-HSA-5689896","Ovarian tumor domain proteases","4/112","27/2914",0.0183264995859557,0.0408453356785027,0.0216236304024177,"APC/CDK1/ESR1/TP53",4
"R-HSA-5693571","R-HSA-5693571","Nonhomologous End-Joining (NHEJ)","4/112","27/2914",0.0183264995859557,0.0408453356785027,0.0216236304024177,"ATM/KAT5/PRKDC/NBN",4
"R-HSA-8986944","R-HSA-8986944","Transcriptional Regulation by MECP2","5/112","41/2914",0.0190460988114579,0.0423108774899489,0.0223994921732558,"PPARG/MET/NCOR1/NCOR2/CREB1",5
"R-HSA-5621481","R-HSA-5621481","C-type lectin receptors (CLRs)","7/112","72/2914",0.0192137772063917,0.0425447923855817,0.0225233273472056,"PAK1/CREBBP/PRKCD/EP300/SRC/RELA/NFATC1",7
"R-HSA-166166","R-HSA-166166","MyD88-independent TLR4 cascade ","8/112","90/2914",0.0207857281940309,0.0457286020268679,0.0242088447217405,"MAPK14/MAPK1/MAPK11/MAPK8/MAPK3/RELA/CREB1/MEF2A",8
"R-HSA-937061","R-HSA-937061","TRIF(TICAM1)-mediated TLR4 signaling ","8/112","90/2914",0.0207857281940309,0.0457286020268679,0.0242088447217405,"MAPK14/MAPK1/MAPK11/MAPK8/MAPK3/RELA/CREB1/MEF2A",8
"R-HSA-8852276","R-HSA-8852276","The role of GTSE1 in G2/M progression after G2 checkpoint","3/112","16/2914",0.0214758545929339,0.0469440154884004,0.0248522878723898,"CDK1/HSP90AA1/TP53",3
"R-HSA-8941858","R-HSA-8941858","Regulation of RUNX3 expression and activity","3/112","16/2914",0.0214758545929339,0.0469440154884004,0.0248522878723898,"MDM2/EP300/SRC",3
"R-HSA-166016","R-HSA-166016","Toll Like Receptor 4 (TLR4) Cascade","9/112","110/2914",0.023783598173631,0.0518224088000523,0.0274349223929896,"MAP3K1/MAPK14/MAPK1/MAPK11/MAPK8/MAPK3/RELA/CREB1/MEF2A",9
"R-HSA-5693567","R-HSA-5693567","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","6/112","59/2914",0.0241851507594248,0.0525295312672858,0.0278092749261908,"UBE2I/ABL1/ATR/ATM/KAT5/NBN",6
"R-HSA-2029485","R-HSA-2029485","Role of phospholipids in phagocytosis","3/112","17/2914",0.0253620683546965,0.0549108908504857,0.0290699730849152,"PIK3CA/PIK3R1/PRKCD",3
"R-HSA-69620","R-HSA-69620","Cell Cycle Checkpoints","9/112","114/2914",0.0292215780720729,0.0628702175550165,0.0332836620178587,"CCNE1/CDK1/MDM2/ATR/ATM/KAT5/TP53/CHEK2/NBN",9
"R-HSA-450531","R-HSA-450531","Regulation of mRNA stability by proteins that bind AU-rich elements","4/112","31/2914",0.0292226671040179,0.0628702175550165,0.0332836620178587,"MAPK14/PRKCD/AKT1/MAPK11",4
"R-HSA-1483255","R-HSA-1483255","PI Metabolism","3/112","18/2914",0.0296007287494151,0.0632843166366805,0.033502887183796,"PIK3CA/PIK3R1/PIK3CG",3
"R-HSA-5654704","R-HSA-5654704","SHC-mediated cascade:FGFR3","3/112","18/2914",0.0296007287494151,0.0632843166366805,0.033502887183796,"GRB2/SHC1/FGFR3",3
"R-HSA-5693538","R-HSA-5693538","Homology Directed Repair","6/112","63/2914",0.0322397168330811,0.0684543070020273,0.0362398939677348,"UBE2I/ABL1/ATR/ATM/KAT5/NBN",6
"R-HSA-1852241","R-HSA-1852241","Organelle biogenesis and maintenance","7/112","80/2914",0.0322507963670456,0.0684543070020273,0.0362398939677348,"CDK1/MAPK14/CREBBP/HSP90AA1/MAPK11/NCOR1/CREB1",7
"R-HSA-5655253","R-HSA-5655253","Signaling by FGFR2 in disease","4/112","32/2914",0.0324358969064433,0.0684543070020273,0.0362398939677348,"PIK3CA/PIK3R1/GRB2/FGF7",4
"R-HSA-8943724","R-HSA-8943724","Regulation of PTEN gene transcription","4/112","32/2914",0.0324358969064433,0.0684543070020273,0.0362398939677348,"MAPK1/PPARG/MAPK3/TP53",4
"R-HSA-438064","R-HSA-438064","Post NMDA receptor activation events","5/112","47/2914",0.0325208144701713,0.0684543070020273,0.0362398939677348,"ERBB4/MAPK1/SRC/MAPK3/CREB1",5
"R-HSA-3371571","R-HSA-3371571","HSF1-dependent transactivation","3/112","19/2914",0.0341897445764493,0.0713070513796282,0.0377501445025659,"CREBBP/HSP90AA1/EP300",3
"R-HSA-5654719","R-HSA-5654719","SHC-mediated cascade:FGFR4","3/112","19/2914",0.0341897445764493,0.0713070513796282,0.0377501445025659,"GRB2/SHC1/FGFR4",3
"R-HSA-9029569","R-HSA-9029569","NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux","3/112","19/2914",0.0341897445764493,0.0713070513796282,0.0377501445025659,"EP300/NCOR1/NCOR2",3
"R-HSA-5693607","R-HSA-5693607","Processing of DNA double-strand break ends","5/112","48/2914",0.0352253136700238,0.0732428778138909,0.0387749762157194,"UBE2I/ATR/ATM/KAT5/NBN",5
"R-HSA-5685942","R-HSA-5685942","HDR through Homologous Recombination (HRR)","4/112","33/2914",0.0358486608287877,0.0743124215356632,0.0393411955343919,"ATR/ATM/KAT5/NBN",4
"R-HSA-442755","R-HSA-442755","Activation of NMDA receptors and postsynaptic events","5/112","49/2914",0.0380655268118342,0.0786687554111241,0.0416474503874295,"ERBB4/MAPK1/SRC/MAPK3/CREB1",5
"R-HSA-8936459","R-HSA-8936459","RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function","3/112","20/2914",0.0391255357740156,0.0803375102203566,0.0425308936650445,"KAT2B/EP300/KMT2A",3
"R-HSA-912631","R-HSA-912631","Regulation of signaling by CBL","3/112","20/2914",0.0391255357740156,0.0803375102203566,0.0425308936650445,"PIK3CA/PIK3R1/GRB2",3
"R-HSA-69275","R-HSA-69275","G2/M Transition","6/112","66/2914",0.0393130513779798,0.0803375102203566,0.0425308936650445,"CDK1/HSP90AA1/EP300/TP53/MYBL2/FOXM1",6
"R-HSA-3214847","R-HSA-3214847","HATs acetylate histones","4/112","34/2914",0.0394619734953365,0.0803375102203566,0.0425308936650445,"KAT2B/CREBBP/EP300/KAT5",4
"R-HSA-3928662","R-HSA-3928662","EPHB-mediated forward signaling","4/112","34/2914",0.0394619734953365,0.0803375102203566,0.0425308936650445,"CDC42/PAK1/PTK2/SRC",4
"R-HSA-5628897","R-HSA-5628897","TP53 Regulates Metabolic Genes","4/112","35/2914",0.0432763495280077,0.0878406856491109,0.0465030948875521,"AKT1/AKT2/AKT3/TP53",4
"R-HSA-5654688","R-HSA-5654688","SHC-mediated cascade:FGFR1","3/112","21/2914",0.0444031901106593,0.0898604618856666,0.0475723698514951,"GRB2/SHC1/FGFR1",3
"R-HSA-8875878","R-HSA-8875878","MET promotes cell motility","4/112","36/2914",0.047291819955333,0.0951750454698705,0.0503859246738163,"GRB2/PTK2/SRC/MET",4
"R-HSA-202733","R-HSA-202733","Cell surface interactions at the vascular wall","6/112","69/2914",0.047308417029745,0.0951750454698705,0.0503859246738163,"PIK3CA/PIK3R1/GRB2/SHC1/SRC/LCK",6
"R-HSA-2173788","R-HSA-2173788","Downregulation of TGF-beta receptor signaling","3/112","22/2914",0.0500166087643522,0.0994499334614816,0.0526490618572128,"SMAD3/SMAD2/PPP1CA",3
"R-HSA-442742","R-HSA-442742","CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling","3/112","22/2914",0.0500166087643522,0.0994499334614816,0.0526490618572128,"MAPK1/MAPK3/CREB1",3
"R-HSA-9022692","R-HSA-9022692","Regulation of MECP2 expression and activity","3/112","22/2914",0.0500166087643522,0.0994499334614816,0.0526490618572128,"NCOR1/NCOR2/CREB1",3
"R-HSA-9024446","R-HSA-9024446","NR1H2 and NR1H3-mediated signaling","3/112","22/2914",0.0500166087643522,0.0994499334614816,0.0526490618572128,"EP300/NCOR1/NCOR2",3
"R-HSA-168898","R-HSA-168898","Toll-like Receptor Cascades","9/112","127/2914",0.0528323758339955,0.104055299716666,0.0550871551208776,"MAP3K1/MAPK14/MAPK1/MAPK11/MAPK8/MAPK3/RELA/CREB1/MEF2A",9
"R-HSA-110056","R-HSA-110056","MAPK3 (ERK1) activation","2/112","10/2914",0.0538585348973362,0.104055299716666,0.0550871551208776,"CDK1/MAPK3",2
"R-HSA-111458","R-HSA-111458","Formation of apoptosome","2/112","10/2914",0.0538585348973362,0.104055299716666,0.0550871551208776,"MAPK1/MAPK3",2
"R-HSA-1221632","R-HSA-1221632","Meiotic synapsis","2/112","10/2914",0.0538585348973362,0.104055299716666,0.0550871551208776,"UBE2I/ATR",2
"R-HSA-381038","R-HSA-381038","XBP1(S) activates chaperone genes","2/112","10/2914",0.0538585348973362,0.104055299716666,0.0550871551208776,"GSK3A/SHC1",2
"R-HSA-4755510","R-HSA-4755510","SUMOylation of immune response proteins","2/112","10/2914",0.0538585348973362,0.104055299716666,0.0550871551208776,"UBE2I/RELA",2
"R-HSA-8875360","R-HSA-8875360","InlB-mediated entry of Listeria monocytogenes into host cell","2/112","10/2914",0.0538585348973362,0.104055299716666,0.0550871551208776,"GRB2/MET",2
"R-HSA-9020956","R-HSA-9020956","Interleukin-27 signaling","2/112","10/2914",0.0538585348973362,0.104055299716666,0.0550871551208776,"STAT1/STAT3",2
"R-HSA-9020958","R-HSA-9020958","Interleukin-21 signaling","2/112","10/2914",0.0538585348973362,0.104055299716666,0.0550871551208776,"STAT1/STAT3",2
"R-HSA-9627069","R-HSA-9627069","Regulation of the apoptosome activity","2/112","10/2914",0.0538585348973362,0.104055299716666,0.0550871551208776,"MAPK1/MAPK3",2
"R-HSA-3247509","R-HSA-3247509","Chromatin modifying enzymes","8/112","109/2914",0.0559151048233672,0.10660277505125,0.0564357954045047,"KAT2B/CREBBP/EP300/KAT5/NCOR1/NCOR2/RELA/KMT2A",8
"R-HSA-4839726","R-HSA-4839726","Chromatin organization","8/112","109/2914",0.0559151048233672,0.10660277505125,0.0564357954045047,"KAT2B/CREBBP/EP300/KAT5/NCOR1/NCOR2/RELA/KMT2A",8
"R-HSA-3108214","R-HSA-3108214","SUMOylation of DNA damage response and repair proteins","4/112","38/2914",0.0559238562869344,0.10660277505125,0.0564357954045047,"PIAS1/UBE2I/PML/TDG",4
"R-HSA-112409","R-HSA-112409","RAF-independent MAPK1/3 activation","3/112","23/2914",0.0559586414491897,0.10660277505125,0.0564357954045047,"CDK1/MAPK1/MAPK3",3
"R-HSA-5654699","R-HSA-5654699","SHC-mediated cascade:FGFR2","3/112","23/2914",0.0559586414491897,0.10660277505125,0.0564357954045047,"GRB2/SHC1/FGF7",3
"R-HSA-109582","R-HSA-109582","Hemostasis","17/112","298/2914",0.0598373159338774,0.113674232498341,0.0601794439680984,"CDC42/MAPK14/PIK3CA/PIK3R1/PRKCD/AKT1/GATA3/GRB2/MAPK1/PIK3CG/PTK2/SHC1/SRC/ABL1/MAPK3/TP53/LCK",17
"R-HSA-1059683","R-HSA-1059683","Interleukin-6 signaling","2/112","11/2914",0.0642097329365735,0.118354156385792,0.062657008242517,"STAT1/STAT3",2
"R-HSA-113510","R-HSA-113510","E2F mediated regulation of DNA replication","2/112","11/2914",0.0642097329365735,0.118354156385792,0.062657008242517,"CDK1/E2F1",2
"R-HSA-1362277","R-HSA-1362277","Transcription of E2F targets under negative control by DREAM complex","2/112","11/2914",0.0642097329365735,0.118354156385792,0.062657008242517,"MYC/E2F1",2
"R-HSA-210990","R-HSA-210990","PECAM1 interactions","2/112","11/2914",0.0642097329365735,0.118354156385792,0.062657008242517,"SRC/LCK",2
"R-HSA-2197563","R-HSA-2197563","NOTCH2 intracellular domain regulates transcription","2/112","11/2914",0.0642097329365735,0.118354156385792,0.062657008242517,"EP300/CREB1",2
"R-HSA-349425","R-HSA-349425","Autodegradation of the E3 ubiquitin ligase COP1","2/112","11/2914",0.0642097329365735,0.118354156385792,0.062657008242517,"ATM/TP53",2
"R-HSA-452723","R-HSA-452723","Transcriptional regulation of pluripotent stem cells","2/112","11/2914",0.0642097329365735,0.118354156385792,0.062657008242517,"SMAD2/STAT3",2
"R-HSA-6803207","R-HSA-6803207","TP53 Regulates Transcription of Caspase Activators and Caspases","2/112","11/2914",0.0642097329365735,0.118354156385792,0.062657008242517,"ATM/TP53",2
"R-HSA-75035","R-HSA-75035","Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex","2/112","11/2914",0.0642097329365735,0.118354156385792,0.062657008242517,"CDK1/CHEK2",2
"R-HSA-8875555","R-HSA-8875555","MET activates RAP1 and RAC1","2/112","11/2914",0.0642097329365735,0.118354156385792,0.062657008242517,"GRB2/MET",2
"R-HSA-8984722","R-HSA-8984722","Interleukin-35 Signalling","2/112","11/2914",0.0642097329365735,0.118354156385792,0.062657008242517,"STAT1/STAT3",2
"R-HSA-456926","R-HSA-456926","Thrombin signalling through proteinase activated receptors (PARs)","3/112","25/2914",0.0687954330069917,0.125786823889459,0.0665918823801274,"MAPK1/SRC/MAPK3",3
"R-HSA-8948751","R-HSA-8948751","Regulation of PTEN stability and activity","3/112","25/2914",0.0687954330069917,0.125786823889459,0.0665918823801274,"AKT1/AKT2/AKT3",3
"R-HSA-9007101","R-HSA-9007101","Rab regulation of trafficking","3/112","25/2914",0.0687954330069917,0.125786823889459,0.0665918823801274,"AKT1/AKT2/AKT3",3
"R-HSA-3858494","R-HSA-3858494","Beta-catenin independent WNT signaling","6/112","76/2914",0.069662351641454,0.127031347110887,0.0672507363158421,"CTNNB1/ROR2/NFATC1/LEF1/TCF7/TCF7L2",6
"R-HSA-112314","R-HSA-112314","Neurotransmitter receptors and postsynaptic signal transmission","6/112","77/2914",0.0732831778134455,0.132803779177392,0.0703066773542916,"MDM2/ERBB4/MAPK1/SRC/MAPK3/CREB1",6
"R-HSA-202403","R-HSA-202403","TCR signaling","5/112","59/2914",0.0740975192085154,0.132803779177392,0.0703066773542916,"PAK1/PIK3CA/PIK3R1/RELA/LCK",5
"R-HSA-111461","R-HSA-111461","Cytochrome c-mediated apoptotic response","2/112","12/2914",0.0751646022910167,0.132803779177392,0.0703066773542916,"MAPK1/MAPK3",2
"R-HSA-1502540","R-HSA-1502540","Signaling by Activin","2/112","12/2914",0.0751646022910167,0.132803779177392,0.0703066773542916,"SMAD3/SMAD2",2
"R-HSA-202670","R-HSA-202670","ERKs are inactivated","2/112","12/2914",0.0751646022910167,0.132803779177392,0.0703066773542916,"MAPK1/MAPK3",2
"R-HSA-381070","R-HSA-381070","IRE1alpha activates chaperones","2/112","12/2914",0.0751646022910167,0.132803779177392,0.0703066773542916,"GSK3A/SHC1",2
"R-HSA-381771","R-HSA-381771","Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)","2/112","12/2914",0.0751646022910167,0.132803779177392,0.0703066773542916,"CTNNB1/TCF7L2",2
"R-HSA-399954","R-HSA-399954","Sema3A PAK dependent Axon repulsion","2/112","12/2914",0.0751646022910167,0.132803779177392,0.0703066773542916,"PAK1/HSP90AA1",2
"R-HSA-9005891","R-HSA-9005891","Loss of function of MECP2 in Rett syndrome","2/112","12/2914",0.0751646022910167,0.132803779177392,0.0703066773542916,"NCOR1/NCOR2",2
"R-HSA-9005895","R-HSA-9005895","Pervasive developmental disorders","2/112","12/2914",0.0751646022910167,0.132803779177392,0.0703066773542916,"NCOR1/NCOR2",2
"R-HSA-9020558","R-HSA-9020558","Interleukin-2 signaling","2/112","12/2914",0.0751646022910167,0.132803779177392,0.0703066773542916,"SHC1/LCK",2
"R-HSA-9022699","R-HSA-9022699","MECP2 regulates neuronal receptors and channels","2/112","12/2914",0.0751646022910167,0.132803779177392,0.0703066773542916,"MET/CREB1",2
"R-HSA-111996","R-HSA-111996","Ca-dependent events","3/112","26/2914",0.0756717160571545,0.133010593688091,0.0704161655116766,"PRKCD/MAPK1/CREB1",3
"R-HSA-182971","R-HSA-182971","EGFR downregulation","3/112","26/2914",0.0756717160571545,0.133010593688091,0.0704161655116766,"CDC42/GRB2/EGFR",3
"R-HSA-202424","R-HSA-202424","Downstream TCR signaling","4/112","43/2914",0.0809402804583021,0.141905581677537,0.0751251960416659,"PIK3CA/PIK3R1/RELA/LCK",4
"R-HSA-165159","R-HSA-165159","mTOR signalling","3/112","27/2914",0.0828398681160545,0.143392868160277,0.0759125694998843,"RPS6KB1/AKT1/AKT2",3
"R-HSA-5617472","R-HSA-5617472","Activation of anterior HOX genes in hindbrain development during early embryogenesis","3/112","27/2914",0.0828398681160545,0.143392868160277,0.0759125694998843,"CREBBP/EP300/NCOR1",3
"R-HSA-5619507","R-HSA-5619507","Activation of HOX genes during differentiation","3/112","27/2914",0.0828398681160545,0.143392868160277,0.0759125694998843,"CREBBP/EP300/NCOR1",3
"R-HSA-8874081","R-HSA-8874081","MET activates PTK2 signaling","3/112","27/2914",0.0828398681160545,0.143392868160277,0.0759125694998843,"PTK2/SRC/MET",3
"R-HSA-8939236","R-HSA-8939236","RUNX1 regulates transcription of genes involved in differentiation of HSCs","3/112","27/2914",0.0828398681160545,0.143392868160277,0.0759125694998843,"GATA3/ABL1/KMT2A",3
"R-HSA-1368082","R-HSA-1368082","RORA activates gene expression","2/112","13/2914",0.0866623763293372,0.147390874455381,0.0780291247695568,"CREBBP/EP300",2
"R-HSA-179812","R-HSA-179812","GRB2 events in EGFR signaling","2/112","13/2914",0.0866623763293372,0.147390874455381,0.0780291247695568,"GRB2/EGFR",2
"R-HSA-372708","R-HSA-372708","p130Cas linkage to MAPK signaling for integrins","2/112","13/2914",0.0866623763293372,0.147390874455381,0.0780291247695568,"PTK2/SRC",2
"R-HSA-5626467","R-HSA-5626467","RHO GTPases activate IQGAPs","2/112","13/2914",0.0866623763293372,0.147390874455381,0.0780291247695568,"CDC42/CTNNB1",2
"R-HSA-5689901","R-HSA-5689901","Metalloprotease DUBs","2/112","13/2914",0.0866623763293372,0.147390874455381,0.0780291247695568,"KAT2B/EP300",2
"R-HSA-8964616","R-HSA-8964616","G beta:gamma signalling through CDC42","2/112","13/2914",0.0866623763293372,0.147390874455381,0.0780291247695568,"CDC42/PAK1",2
"R-HSA-912446","R-HSA-912446","Meiotic recombination","2/112","13/2914",0.0866623763293372,0.147390874455381,0.0780291247695568,"ATM/NBN",2
"R-HSA-2173789","R-HSA-2173789","TGF-beta receptor signaling activates SMADs","3/112","28/2914",0.0902891845459794,0.15279708153935,0.0808911853187174,"SMAD3/SMAD2/PPP1CA",3
"R-HSA-8957322","R-HSA-8957322","Metabolism of steroids","3/112","28/2914",0.0902891845459794,0.15279708153935,0.0808911853187174,"UBE2I/CREBBP/SP1",3
"R-HSA-2559582","R-HSA-2559582","Senescence-Associated Secretory Phenotype (SASP)","4/112","45/2914",0.0922699104980316,0.155377972739895,0.0822575160515265,"MAPK1/STAT3/MAPK3/RELA",4
"R-HSA-512988","R-HSA-512988","Interleukin-3, Interleukin-5 and GM-CSF signaling","4/112","45/2914",0.0922699104980316,0.155377972739895,0.0822575160515265,"PIK3CA/PIK3R1/GRB2/SHC1",4
"R-HSA-194315","R-HSA-194315","Signaling by Rho GTPases","13/112","228/2914",0.0945890797012297,0.15889101565576,0.0841173304058122,"AR/CDC42/CTNNB1/MAPK14/PAK1/PRKCD/GRB2/MAPK1/MAPK11/PTK2/SRC/ABL1/MAPK3",13
"R-HSA-2871809","R-HSA-2871809","FCERI mediated Ca+2 mobilization","3/112","29/2914",0.0980085332362781,0.162503788972119,0.0860299423019551,"GRB2/SHC1/NFATC1",3
"R-HSA-2426168","R-HSA-2426168","Activation of gene expression by SREBF (SREBP)","2/112","14/2914",0.0986459950651864,0.162503788972119,0.0860299423019551,"CREBBP/SP1",2
"R-HSA-373753","R-HSA-373753","Nephrin family interactions","2/112","14/2914",0.0986459950651864,0.162503788972119,0.0860299423019551,"PIK3CA/PIK3R1",2
"R-HSA-400508","R-HSA-400508","Incretin synthesis, secretion, and inactivation","2/112","14/2914",0.0986459950651864,0.162503788972119,0.0860299423019551,"CTNNB1/TCF7L2",2
"R-HSA-877312","R-HSA-877312","Regulation of IFNG signaling","2/112","14/2914",0.0986459950651864,0.162503788972119,0.0860299423019551,"PIAS1/STAT1",2
"R-HSA-9027284","R-HSA-9027284","Erythropoietin activates RAS","2/112","14/2914",0.0986459950651864,0.162503788972119,0.0860299423019551,"GRB2/SHC1",2
"R-HSA-918233","R-HSA-918233","TRAF3-dependent IRF activation pathway","2/112","14/2914",0.0986459950651864,0.162503788972119,0.0860299423019551,"CREBBP/EP300",2
"R-HSA-9620244","R-HSA-9620244","Long-term potentiation","2/112","14/2914",0.0986459950651864,0.162503788972119,0.0860299423019551,"ERBB4/SRC",2
"R-HSA-877300","R-HSA-877300","Interferon gamma signaling","4/112","47/2914",0.104315251562551,0.171428919435325,0.0907549303385037,"PIAS1/STAT1/PRKCD/PML",4
"R-HSA-1483257","R-HSA-1483257","Phospholipid metabolism","3/112","30/2914",0.105986432292236,0.1729252316347,0.0915470820353483,"PIK3CA/PIK3R1/PIK3CG",3
"R-HSA-390466","R-HSA-390466","Chaperonin-mediated protein folding","3/112","30/2914",0.105986432292236,0.1729252316347,0.0915470820353483,"CCNE1/STAT3/TP53",3
"R-HSA-5633008","R-HSA-5633008","TP53 Regulates Transcription of Cell Death Genes","3/112","30/2914",0.105986432292236,0.1729252316347,0.0915470820353483,"CREBBP/ATM/TP53",3
"R-HSA-400685","R-HSA-400685","Sema4D in semaphorin signaling","2/112","15/2914",0.111061914105565,0.180343393857131,0.0954742770381171,"ERBB2/MET",2
"R-HSA-9008059","R-HSA-9008059","Interleukin-37 signaling","2/112","15/2914",0.111061914105565,0.180343393857131,0.0954742770381171,"SMAD3/STAT3",2
"R-HSA-391251","R-HSA-391251","Protein folding","3/112","31/2914",0.114211121419545,0.185016590993182,0.0979482801522786,"CCNE1/STAT3/TP53",3
"R-HSA-112315","R-HSA-112315","Transmission across Chemical Synapses","6/112","88/2914",0.120034812336446,0.193989909984494,0.102698779325022,"MDM2/ERBB4/MAPK1/SRC/MAPK3/CREB1",6
"R-HSA-2151201","R-HSA-2151201","Transcriptional activation of mitochondrial biogenesis","3/112","32/2914",0.122670627403659,0.196447598181921,0.103999886057106,"CREBBP/NCOR1/CREB1",3
"R-HSA-447115","R-HSA-447115","Interleukin-12 family signaling","3/112","32/2914",0.122670627403659,0.196447598181921,0.103999886057106,"CDC42/STAT1/STAT3",3
"R-HSA-6802948","R-HSA-6802948","Signaling by high-kinase activity BRAF mutants","3/112","32/2914",0.122670627403659,0.196447598181921,0.103999886057106,"MAPK1/SRC/MAPK3",3
"R-HSA-111471","R-HSA-111471","Apoptotic factor-mediated response","2/112","16/2914",0.123859922607369,0.196447598181921,0.103999886057106,"MAPK1/MAPK3",2
"R-HSA-3214815","R-HSA-3214815","HDACs deacetylate histones","2/112","16/2914",0.123859922607369,0.196447598181921,0.103999886057106,"NCOR1/NCOR2",2
"R-HSA-3928664","R-HSA-3928664","Ephrin signaling","2/112","16/2914",0.123859922607369,0.196447598181921,0.103999886057106,"PAK1/SRC",2
"R-HSA-5627123","R-HSA-5627123","RHO GTPases activate PAKs","2/112","16/2914",0.123859922607369,0.196447598181921,0.103999886057106,"CDC42/PAK1",2
"R-HSA-6807004","R-HSA-6807004","Negative regulation of MET activity","2/112","16/2914",0.123859922607369,0.196447598181921,0.103999886057106,"GRB2/MET",2
"R-HSA-68875","R-HSA-68875","Mitotic Prophase","3/112","33/2914",0.131352824061146,0.207848320208124,0.110035458915553,"CDK1/MAPK1/MAPK3",3
"R-HSA-418592","R-HSA-418592","ADP signalling through P2Y purinoceptor 1","2/112","17/2914",0.136992969841059,0.21627130886945,0.114494611733634,"MAPK14/SRC",2
"R-HSA-112040","R-HSA-112040","G-protein mediated events","3/112","34/2914",0.140245487019127,0.219374821438176,0.11613761962231,"PRKCD/MAPK1/CREB1",3
"R-HSA-112043","R-HSA-112043","PLC beta mediated events","3/112","34/2914",0.140245487019127,0.219374821438176,0.11613761962231,"PRKCD/MAPK1/CREB1",3
"R-HSA-5674135","R-HSA-5674135","MAP2K and MAPK activation","3/112","34/2914",0.140245487019127,0.219374821438176,0.11613761962231,"MAPK1/SRC/MAPK3",3
"R-HSA-6796648","R-HSA-6796648","TP53 Regulates Transcription of DNA Repair Genes","3/112","34/2914",0.140245487019127,0.219374821438176,0.11613761962231,"ATR/ATM/TP53",3
"R-HSA-5607764","R-HSA-5607764","CLEC7A (Dectin-1) signaling","4/112","53/2914",0.144398318779346,0.225353897957699,0.119302958789151,"PRKCD/SRC/RELA/NFATC1",4
"R-HSA-202433","R-HSA-202433","Generation of second messenger molecules","2/112","18/2914",0.150416999977514,0.233677435044795,0.123709461676747,"PAK1/LCK",2
"R-HSA-69273","R-HSA-69273","Cyclin A/B1/B2 associated events during G2/M transition","2/112","18/2914",0.150416999977514,0.233677435044795,0.123709461676747,"CDK1/FOXM1",2
"R-HSA-5218921","R-HSA-5218921","VEGFR2 mediated cell proliferation","2/112","19/2914",0.164090794730581,0.254340731832401,0.134648666489448,"PRKCD/SRC",2
"R-HSA-1655829","R-HSA-1655829","Regulation of cholesterol biosynthesis by SREBP (SREBF)","2/112","20/2914",0.177975823503533,0.272762947481819,0.144401436928945,"CREBBP/SP1",2
"R-HSA-437239","R-HSA-437239","Recycling pathway of L1","2/112","20/2914",0.177975823503533,0.272762947481819,0.144401436928945,"MAPK1/SRC",2
"R-HSA-5654706","R-HSA-5654706","FRS-mediated FGFR3 signaling","2/112","20/2914",0.177975823503533,0.272762947481819,0.144401436928945,"GRB2/FGFR3",2
"R-HSA-73854","R-HSA-73854","RNA Polymerase I Promoter Clearance","2/112","20/2914",0.177975823503533,0.272762947481819,0.144401436928945,"KAT2B/MAPK3",2
"R-HSA-73864","R-HSA-73864","RNA Polymerase I Transcription","2/112","20/2914",0.177975823503533,0.272762947481819,0.144401436928945,"KAT2B/MAPK3",2
"R-HSA-111885","R-HSA-111885","Opioid Signalling","4/112","59/2914",0.189551381580654,0.289852112641269,0.153448486859014,"PRKCD/MAPK1/PPP1CA/CREB1",4
"R-HSA-450302","R-HSA-450302","activated TAK1 mediates p38 MAPK activation","2/112","21/2914",0.192036100702782,0.291689578350329,0.154421246140088,"MAPK14/MAPK11",2
"R-HSA-5654712","R-HSA-5654712","FRS-mediated FGFR4 signaling","2/112","21/2914",0.192036100702782,0.291689578350329,0.154421246140088,"GRB2/FGFR4",2
"R-HSA-933542","R-HSA-933542","TRAF6 mediated NF-kB activation","2/112","21/2914",0.192036100702782,0.291689578350329,0.154421246140088,"MAP3K1/RELA",2
"R-HSA-69231","R-HSA-69231","Cyclin D associated events in G1","3/112","40/2914",0.197335992363663,0.298410525037735,0.157979333366172,"SRC/ABL1/E2F1",3
"R-HSA-69236","R-HSA-69236","G1 Phase","3/112","40/2914",0.197335992363663,0.298410525037735,0.157979333366172,"SRC/ABL1/E2F1",3
"R-HSA-1266695","R-HSA-1266695","Interleukin-7 signaling","2/112","22/2914",0.206238049896625,0.310495253928253,0.164377021295556,"PIK3R1/STAT3",2
"R-HSA-8866654","R-HSA-8866654","E3 ubiquitin ligases ubiquitinate target proteins","2/112","22/2914",0.206238049896625,0.310495253928253,0.164377021295556,"CDC73/PRKDC",2
"R-HSA-983231","R-HSA-983231","Factors involved in megakaryocyte development and platelet production","4/112","62/2914",0.213654441294661,0.320952266438236,0.16991299180169,"CDC42/GATA3/ABL1/TP53",4
"R-HSA-112316","R-HSA-112316","Neuronal System","6/112","105/2914",0.214470364199528,0.321469864580392,0.170187009648209,"MDM2/ERBB4/MAPK1/SRC/MAPK3/CREB1",6
"R-HSA-1430728","R-HSA-1430728","Metabolism","14/112","289/2914",0.215368278270978,0.322107819694752,0.170524744799043,"UBE2I/CREBBP/HSP90AA1/PIK3CA/PIK3R1/AKT1/EP300/PIK3CG/PPARG/PPP1CA/NCOR1/NCOR2/ARNT/SP1",14
"R-HSA-6802946","R-HSA-6802946","Signaling by moderate kinase activity BRAF mutants","3/112","42/2914",0.217499859145962,0.322467182472926,0.170714992418913,"MAPK1/SRC/MAPK3",3
"R-HSA-6802949","R-HSA-6802949","Signaling by RAS mutants","3/112","42/2914",0.217499859145962,0.322467182472926,0.170714992418913,"MAPK1/SRC/MAPK3",3
"R-HSA-6802955","R-HSA-6802955","Paradoxical activation of RAF signaling by kinase inactive BRAF","3/112","42/2914",0.217499859145962,0.322467182472926,0.170714992418913,"MAPK1/SRC/MAPK3",3
"R-HSA-9649948","R-HSA-9649948","Signaling downstream of RAS mutants","3/112","42/2914",0.217499859145962,0.322467182472926,0.170714992418913,"MAPK1/SRC/MAPK3",3
"R-HSA-392518","R-HSA-392518","Signal amplification","2/112","23/2914",0.220550374510667,0.324171024604041,0.171617011018963,"MAPK14/SRC",2
"R-HSA-4551638","R-HSA-4551638","SUMOylation of chromatin organization proteins","2/112","23/2914",0.220550374510667,0.324171024604041,0.171617011018963,"PIAS1/UBE2I",2
"R-HSA-5654693","R-HSA-5654693","FRS-mediated FGFR1 signaling","2/112","23/2914",0.220550374510667,0.324171024604041,0.171617011018963,"GRB2/FGFR1",2
"R-HSA-6783589","R-HSA-6783589","Interleukin-6 family signaling","2/112","23/2914",0.220550374510667,0.324171024604041,0.171617011018963,"STAT1/STAT3",2
"R-HSA-983705","R-HSA-983705","Signaling by the B Cell Receptor (BCR)","4/112","63/2914",0.221876349402615,0.325418645790502,0.172277505025687,"PIK3R1/GRB2/RELA/NFATC1",4
"R-HSA-376176","R-HSA-376176","Signaling by ROBO receptors","4/112","64/2914",0.230182322267268,0.336876274219478,0.178343204286589,"CDC42/PAK1/SRC/ABL1",4
"R-HSA-5625740","R-HSA-5625740","RHO GTPases activate PKNs","2/112","24/2914",0.234943934764872,0.342375563054792,0.181254542564892,"AR/PAK1",2
"R-HSA-8854691","R-HSA-8854691","Interleukin-20 family signaling","2/112","24/2914",0.234943934764872,0.342375563054792,0.181254542564892,"STAT1/STAT3",2
"R-HSA-168928","R-HSA-168928","DDX58/IFIH1-mediated induction of interferon-alpha/beta","4/112","66/2914",0.247023264336426,0.358829308119568,0.189965199390356,"MAP3K1/CREBBP/EP300/RELA",4
"R-HSA-111933","R-HSA-111933","Calmodulin induced events","2/112","25/2914",0.249391630569905,0.358829308119568,0.189965199390356,"PRKCD/CREB1",2
"R-HSA-111997","R-HSA-111997","CaM pathway","2/112","25/2914",0.249391630569905,0.358829308119568,0.189965199390356,"PRKCD/CREB1",2
"R-HSA-380259","R-HSA-380259","Loss of Nlp from mitotic centrosomes","2/112","25/2914",0.249391630569905,0.358829308119568,0.189965199390356,"CDK1/HSP90AA1",2
"R-HSA-380284","R-HSA-380284","Loss of proteins required for interphase microtubule organization from the centrosome","2/112","25/2914",0.249391630569905,0.358829308119568,0.189965199390356,"CDK1/HSP90AA1",2
"R-HSA-5654700","R-HSA-5654700","FRS-mediated FGFR2 signaling","2/112","25/2914",0.249391630569905,0.358829308119568,0.189965199390356,"GRB2/FGF7",2
"R-HSA-6802952","R-HSA-6802952","Signaling by BRAF and RAF fusions","3/112","46/2914",0.258975296019219,0.371834003968647,0.196849920298265,"MAPK1/SRC/MAPK3",3
"R-HSA-1445148","R-HSA-1445148","Translocation of SLC2A4 (GLUT4) to the plasma membrane","2/112","26/2914",0.263868290112634,0.376069909317814,0.19909241996606,"AKT1/AKT2",2
"R-HSA-380320","R-HSA-380320","Recruitment of NuMA to mitotic centrosomes","2/112","26/2914",0.263868290112634,0.376069909317814,0.19909241996606,"CDK1/HSP90AA1",2
"R-HSA-8854518","R-HSA-8854518","AURKA Activation by TPX2","2/112","26/2914",0.263868290112634,0.376069909317814,0.19909241996606,"CDK1/HSP90AA1",2
"R-HSA-2682334","R-HSA-2682334","EPH-Ephrin signaling","4/112","68/2914",0.26413121196955,0.376069909317814,0.19909241996606,"CDC42/PAK1/PTK2/SRC",4
"R-HSA-380270","R-HSA-380270","Recruitment of mitotic centrosome proteins and complexes","2/112","27/2914",0.278350563872361,0.393033301368427,0.208072885274534,"CDK1/HSP90AA1",2
"R-HSA-380287","R-HSA-380287","Centrosome maturation","2/112","27/2914",0.278350563872361,0.393033301368427,0.208072885274534,"CDK1/HSP90AA1",2
"R-HSA-8852135","R-HSA-8852135","Protein ubiquitination","2/112","27/2914",0.278350563872361,0.393033301368427,0.208072885274534,"CDC73/PRKDC",2
"R-HSA-983695","R-HSA-983695","Antigen activates B Cell Receptor (BCR) leading to generation of second messengers","2/112","27/2914",0.278350563872361,0.393033301368427,0.208072885274534,"PIK3R1/GRB2",2
"R-HSA-168643","R-HSA-168643","Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways","3/112","48/2914",0.280115241986557,0.394707840981058,0.208959391042603,"MAPK14/MAPK11/RELA",3
"R-HSA-6802957","R-HSA-6802957","Oncogenic MAPK signaling","3/112","49/2914",0.290750367205808,0.408848969967755,0.216445742705572,"MAPK1/SRC/MAPK3",3
"R-HSA-5620912","R-HSA-5620912","Anchoring of the basal body to the plasma membrane","2/112","28/2914",0.292816823820544,0.410063806664499,0.217088880515393,"CDK1/HSP90AA1",2
"R-HSA-933541","R-HSA-933541","TRAF6 mediated IRF7 activation","2/112","28/2914",0.292816823820544,0.410063806664499,0.217088880515393,"CREBBP/EP300",2
"R-HSA-416476","R-HSA-416476","G alpha (q) signalling events","8/112","165/2914",0.299308178892976,0.418295446731577,0.221446732873794,"PIK3CA/PIK3R1/PRKCD/GRB2/MAPK1/EGFR/MAPK3/CREB1",8
"R-HSA-1980145","R-HSA-1980145","Signaling by NOTCH2","2/112","29/2914",0.307247067567527,0.427637755267456,0.226392576102388,"EP300/CREB1",2
"R-HSA-381119","R-HSA-381119","Unfolded Protein Response (UPR)","2/112","29/2914",0.307247067567527,0.427637755267456,0.226392576102388,"GSK3A/SHC1",2
"R-HSA-913531","R-HSA-913531","Interferon Signaling","5/112","97/2914",0.316103948451173,0.439069028194909,0.232444322690004,"PIAS1/STAT1/PRKCD/PML/MAPK3",5
"R-HSA-1489509","R-HSA-1489509","DAG and IP3 signaling","2/112","30/2914",0.321622827230048,0.440206264378642,0.233046378579834,"PRKCD/CREB1",2
"R-HSA-5696395","R-HSA-5696395","Formation of Incision Complex in GG-NER","2/112","30/2914",0.321622827230048,0.440206264378642,0.233046378579834,"PIAS1/UBE2I",2
"R-HSA-113501","R-HSA-113501","Inhibition of replication initiation of damaged DNA by RB1/E2F1","1/112","10/2914",0.324668256572518,0.440206264378642,0.233046378579834,"E2F1",1
"R-HSA-114508","R-HSA-114508","Effects of PIP2 hydrolysis","1/112","10/2914",0.324668256572518,0.440206264378642,0.233046378579834,"PRKCD",1
"R-HSA-164938","R-HSA-164938","Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters","1/112","10/2914",0.324668256572518,0.440206264378642,0.233046378579834,"LCK",1
"R-HSA-2025928","R-HSA-2025928","Calcineurin activates NFAT","1/112","10/2914",0.324668256572518,0.440206264378642,0.233046378579834,"NFATC1",1
"R-HSA-2029481","R-HSA-2029481","FCGR activation","1/112","10/2914",0.324668256572518,0.440206264378642,0.233046378579834,"SRC",1
"R-HSA-209560","R-HSA-209560","NF-kB is activated and signals survival","1/112","10/2914",0.324668256572518,0.440206264378642,0.233046378579834,"RELA",1
"R-HSA-211945","R-HSA-211945","Phase I - Functionalization of compounds","1/112","10/2914",0.324668256572518,0.440206264378642,0.233046378579834,"ARNT",1
"R-HSA-3371511","R-HSA-3371511","HSF1 activation","1/112","10/2914",0.324668256572518,0.440206264378642,0.233046378579834,"HSP90AA1",1
"R-HSA-442729","R-HSA-442729","CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde","1/112","10/2914",0.324668256572518,0.440206264378642,0.233046378579834,"CREB1",1
"R-HSA-8934903","R-HSA-8934903","Receptor Mediated Mitophagy","1/112","10/2914",0.324668256572518,0.440206264378642,0.233046378579834,"SRC",1
"R-HSA-196854","R-HSA-196854","Metabolism of vitamins and cofactors","2/112","31/2914",0.335927082803186,0.453667862320342,0.240172984682632,"HSP90AA1/AKT1",2
"R-HSA-3214841","R-HSA-3214841","PKMTs methylate histone lysines","2/112","31/2914",0.335927082803186,0.453667862320342,0.240172984682632,"RELA/KMT2A",2
"R-HSA-1834941","R-HSA-1834941","STING mediated induction of host immune responses","1/112","11/2914",0.350714108936112,0.461751008290402,0.244452223867275,"PRKDC",1
"R-HSA-1839122","R-HSA-1839122","Signaling by activated point mutants of FGFR1","1/112","11/2914",0.350714108936112,0.461751008290402,0.244452223867275,"FGFR1",1
"R-HSA-190373","R-HSA-190373","FGFR1c ligand binding and activation","1/112","11/2914",0.350714108936112,0.461751008290402,0.244452223867275,"FGFR1",1
"R-HSA-193692","R-HSA-193692","Regulated proteolysis of p75NTR","1/112","11/2914",0.350714108936112,0.461751008290402,0.244452223867275,"RELA",1
"R-HSA-2586552","R-HSA-2586552","Signaling by Leptin","1/112","11/2914",0.350714108936112,0.461751008290402,0.244452223867275,"STAT3",1
"R-HSA-416572","R-HSA-416572","Sema4D induced cell migration and growth-cone collapse","1/112","11/2914",0.350714108936112,0.461751008290402,0.244452223867275,"ERBB2",1
"R-HSA-5607763","R-HSA-5607763","CLEC7A (Dectin-1) induces NFAT activation","1/112","11/2914",0.350714108936112,0.461751008290402,0.244452223867275,"NFATC1",1
"R-HSA-5627117","R-HSA-5627117","RHO GTPases Activate ROCKs","1/112","11/2914",0.350714108936112,0.461751008290402,0.244452223867275,"PAK1",1
"R-HSA-69601","R-HSA-69601","Ubiquitin Mediated Degradation of Phosphorylated Cdc25A","1/112","11/2914",0.350714108936112,0.461751008290402,0.244452223867275,"CHEK2",1
"R-HSA-69610","R-HSA-69610","p53-Independent DNA Damage Response","1/112","11/2914",0.350714108936112,0.461751008290402,0.244452223867275,"CHEK2",1
"R-HSA-69613","R-HSA-69613","p53-Independent G1/S DNA damage checkpoint","1/112","11/2914",0.350714108936112,0.461751008290402,0.244452223867275,"CHEK2",1
"R-HSA-75815","R-HSA-75815","Ubiquitin-dependent degradation of Cyclin D","1/112","11/2914",0.350714108936112,0.461751008290402,0.244452223867275,"GSK3B",1
"R-HSA-9028731","R-HSA-9028731","Activated NTRK2 signals through FRS2 and FRS3","1/112","11/2914",0.350714108936112,0.461751008290402,0.244452223867275,"GRB2",1
"R-HSA-5696398","R-HSA-5696398","Nucleotide Excision Repair","3/112","55/2914",0.354896741641776,0.465739088474722,0.246563524227241,"PIAS1/UBE2I/EP300",3
"R-HSA-5663205","R-HSA-5663205","Infectious disease","6/112","126/2914",0.355108982414744,0.465739088474722,0.246563524227241,"CTNNB1/HSP90AA1/GRB2/SRC/MET/LCK",6
"R-HSA-168638","R-HSA-168638","NOD1/2 Signaling Pathway","2/112","33/2914",0.364259751169735,0.476823704986102,0.252431749977208,"MAPK14/MAPK11",2
"R-HSA-111932","R-HSA-111932","CaMK IV-mediated phosphorylation of CREB","1/112","12/2914",0.375764064085666,0.479011386367148,0.25358991437557,"CREB1",1
"R-HSA-1839130","R-HSA-1839130","Signaling by activated point mutants of FGFR3","1/112","12/2914",0.375764064085666,0.479011386367148,0.25358991437557,"FGFR3",1
"R-HSA-190239","R-HSA-190239","FGFR3 ligand binding and activation","1/112","12/2914",0.375764064085666,0.479011386367148,0.25358991437557,"FGFR3",1
"R-HSA-190372","R-HSA-190372","FGFR3c ligand binding and activation","1/112","12/2914",0.375764064085666,0.479011386367148,0.25358991437557,"FGFR3",1
"R-HSA-202427","R-HSA-202427","Phosphorylation of CD3 and TCR zeta chains","1/112","12/2914",0.375764064085666,0.479011386367148,0.25358991437557,"LCK",1
"R-HSA-2032785","R-HSA-2032785","YAP1- and WWTR1 (TAZ)-stimulated gene expression","1/112","12/2914",0.375764064085666,0.479011386367148,0.25358991437557,"KAT2B",1
"R-HSA-2033514","R-HSA-2033514","FGFR3 mutant receptor activation","1/112","12/2914",0.375764064085666,0.479011386367148,0.25358991437557,"FGFR3",1
"R-HSA-2691230","R-HSA-2691230","Signaling by NOTCH1 HD Domain Mutants in Cancer","1/112","12/2914",0.375764064085666,0.479011386367148,0.25358991437557,"NOTCH1",1
"R-HSA-2691232","R-HSA-2691232","Constitutive Signaling by NOTCH1 HD Domain Mutants","1/112","12/2914",0.375764064085666,0.479011386367148,0.25358991437557,"NOTCH1",1
"R-HSA-3301854","R-HSA-3301854","Nuclear Pore Complex (NPC) Disassembly","1/112","12/2914",0.375764064085666,0.479011386367148,0.25358991437557,"CDK1",1
"R-HSA-389948","R-HSA-389948","PD-1 signaling","1/112","12/2914",0.375764064085666,0.479011386367148,0.25358991437557,"LCK",1
"R-HSA-418990","R-HSA-418990","Adherens junctions interactions","1/112","12/2914",0.375764064085666,0.479011386367148,0.25358991437557,"CTNNB1",1
"R-HSA-442720","R-HSA-442720","CREB1 phosphorylation through the activation of Adenylate Cyclase","1/112","12/2914",0.375764064085666,0.479011386367148,0.25358991437557,"CREB1",1
"R-HSA-844456","R-HSA-844456","The NLRP3 inflammasome","1/112","12/2914",0.375764064085666,0.479011386367148,0.25358991437557,"RELA",1
"R-HSA-1169408","R-HSA-1169408","ISG15 antiviral mechanism","2/112","34/2914",0.378260642679148,0.480398060162345,0.254324023206798,"STAT1/MAPK3",2
"R-HSA-5675221","R-HSA-5675221","Negative regulation of MAPK pathway","2/112","34/2914",0.378260642679148,0.480398060162345,0.254324023206798,"MAPK1/MAPK3",2
"R-HSA-446652","R-HSA-446652","Interleukin-1 family signaling","4/112","82/2914",0.387708650627755,0.491481969754887,0.260191874712033,"SMAD3/MAPK8/STAT3/RELA",4
"R-HSA-1169410","R-HSA-1169410","Antiviral mechanism by IFN-stimulated genes","2/112","35/2914",0.392134842619768,0.495251782716077,0.262187623817895,"STAT1/MAPK3",2
"R-HSA-446728","R-HSA-446728","Cell junction organization","2/112","35/2914",0.392134842619768,0.495251782716077,0.262187623817895,"CTNNB1/ITGB4",2
"R-HSA-111931","R-HSA-111931","PKA-mediated phosphorylation of CREB","1/112","13/2914",0.399855871398693,0.496724415835899,0.262967239746432,"CREB1",1
"R-HSA-190322","R-HSA-190322","FGFR4 ligand binding and activation","1/112","13/2914",0.399855871398693,0.496724415835899,0.262967239746432,"FGFR4",1
"R-HSA-193639","R-HSA-193639","p75NTR signals via NF-kB","1/112","13/2914",0.399855871398693,0.496724415835899,0.262967239746432,"RELA",1
"R-HSA-205043","R-HSA-205043","NRIF signals cell death from the nucleus","1/112","13/2914",0.399855871398693,0.496724415835899,0.262967239746432,"MAPK8",1
"R-HSA-3906995","R-HSA-3906995","Diseases associated with O-glycosylation of proteins","1/112","13/2914",0.399855871398693,0.496724415835899,0.262967239746432,"NOTCH1",1
"R-HSA-4085377","R-HSA-4085377","SUMOylation of SUMOylation proteins","1/112","13/2914",0.399855871398693,0.496724415835899,0.262967239746432,"UBE2I",1
"R-HSA-428540","R-HSA-428540","Activation of RAC1","1/112","13/2914",0.399855871398693,0.496724415835899,0.262967239746432,"PAK1",1
"R-HSA-5654227","R-HSA-5654227","Phospholipase C-mediated cascade; FGFR3","1/112","13/2914",0.399855871398693,0.496724415835899,0.262967239746432,"FGFR3",1
"R-HSA-6807505","R-HSA-6807505","RNA polymerase II transcribes snRNA genes","1/112","13/2914",0.399855871398693,0.496724415835899,0.262967239746432,"SP1",1
"R-HSA-5653656","R-HSA-5653656","Vesicle-mediated transport","7/112","160/2914",0.41865154879281,0.518891434903191,0.274702519172395,"HSP90AA1/AKT1/AKT2/AKT3/GRB2/SRC/EGFR",7
"R-HSA-2565942","R-HSA-2565942","Regulation of PLK1 Activity at G2/M Transition","2/112","37/2914",0.419460434053737,0.518891434903191,0.274702519172395,"CDK1/HSP90AA1",2
"R-HSA-211859","R-HSA-211859","Biological oxidations","1/112","14/2914",0.423025861885886,0.518891434903191,0.274702519172395,"ARNT",1
"R-HSA-445355","R-HSA-445355","Smooth Muscle Contraction","1/112","14/2914",0.423025861885886,0.518891434903191,0.274702519172395,"PAK1",1
"R-HSA-4641257","R-HSA-4641257","Degradation of AXIN","1/112","14/2914",0.423025861885886,0.518891434903191,0.274702519172395,"AXIN1",1
"R-HSA-5654228","R-HSA-5654228","Phospholipase C-mediated cascade; FGFR4","1/112","14/2914",0.423025861885886,0.518891434903191,0.274702519172395,"FGFR4",1
"R-HSA-68867","R-HSA-68867","Assembly of the pre-replicative complex","1/112","14/2914",0.423025861885886,0.518891434903191,0.274702519172395,"E2F1",1
"R-HSA-176412","R-HSA-176412","Phosphorylation of the APC/C","1/112","15/2914",0.445309001013052,0.540392773471355,0.286085385554367,"CDK1",1
"R-HSA-190242","R-HSA-190242","FGFR1 ligand binding and activation","1/112","15/2914",0.445309001013052,0.540392773471355,0.286085385554367,"FGFR1",1
"R-HSA-432142","R-HSA-432142","Platelet sensitization by LDL","1/112","15/2914",0.445309001013052,0.540392773471355,0.286085385554367,"MAPK14",1
"R-HSA-8862803","R-HSA-8862803","Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models","1/112","15/2914",0.445309001013052,0.540392773471355,0.286085385554367,"FOXO3",1
"R-HSA-8863678","R-HSA-8863678","Neurodegenerative Diseases","1/112","15/2914",0.445309001013052,0.540392773471355,0.286085385554367,"FOXO3",1
"R-HSA-9604323","R-HSA-9604323","Negative regulation of NOTCH4 signaling","1/112","15/2914",0.445309001013052,0.540392773471355,0.286085385554367,"AKT1",1
"R-HSA-1168372","R-HSA-1168372","Downstream signaling events of B Cell Receptor (BCR)","2/112","39/2914",0.446160815890477,0.540464789409068,0.286123510985199,"RELA/NFATC1",2
"R-HSA-166208","R-HSA-166208","mTORC1-mediated signalling","1/112","16/2914",0.466738939573431,0.556496427952937,0.294610703484885,"RPS6KB1",1
"R-HSA-176187","R-HSA-176187","Activation of ATR in response to replication stress","1/112","16/2914",0.466738939573431,0.556496427952937,0.294610703484885,"ATR",1
"R-HSA-1810476","R-HSA-1810476","RIP-mediated NFkB activation via ZBP1","1/112","16/2914",0.466738939573431,0.556496427952937,0.294610703484885,"RELA",1
"R-HSA-211000","R-HSA-211000","Gene Silencing by RNA","1/112","16/2914",0.466738939573431,0.556496427952937,0.294610703484885,"HSP90AA1",1
"R-HSA-5205647","R-HSA-5205647","Mitophagy","1/112","16/2914",0.466738939573431,0.556496427952937,0.294610703484885,"SRC",1
"R-HSA-5654219","R-HSA-5654219","Phospholipase C-mediated cascade: FGFR1","1/112","16/2914",0.466738939573431,0.556496427952937,0.294610703484885,"FGFR1",1
"R-HSA-622312","R-HSA-622312","Inflammasomes","1/112","16/2914",0.466738939573431,0.556496427952937,0.294610703484885,"RELA",1
"R-HSA-73933","R-HSA-73933","Resolution of Abasic Sites (AP sites)","1/112","16/2914",0.466738939573431,0.556496427952937,0.294610703484885,"TDG",1
"R-HSA-8950505","R-HSA-8950505","Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation","1/112","16/2914",0.466738939573431,0.556496427952937,0.294610703484885,"CDC42",1
"R-HSA-1280218","R-HSA-1280218","Adaptive Immune System","12/112","296/2914",0.468638185101402,0.557785763070081,0.295293280958539,"CDC42/PAK1/PIK3CA/PIK3R1/AKT1/AKT2/AKT3/GRB2/SRC/RELA/LCK/NFATC1",12
"R-HSA-199991","R-HSA-199991","Membrane Trafficking","6/112","144/2914",0.480986219700421,0.56815620298961,0.300783419702788,"AKT1/AKT2/AKT3/GRB2/SRC/EGFR",6
"R-HSA-2980736","R-HSA-2980736","Peptide hormone metabolism","2/112","42/2914",0.484908343230706,0.56815620298961,0.300783419702788,"CTNNB1/TCF7L2",2
"R-HSA-5617833","R-HSA-5617833","Cilium Assembly","2/112","42/2914",0.484908343230706,0.56815620298961,0.300783419702788,"CDK1/HSP90AA1",2
"R-HSA-164952","R-HSA-164952","The role of Nef in HIV-1 replication and disease pathogenesis","1/112","17/2914",0.487348062681704,0.56815620298961,0.300783419702788,"LCK",1
"R-HSA-174048","R-HSA-174048","APC/C:Cdc20 mediated degradation of Cyclin B","1/112","17/2914",0.487348062681704,0.56815620298961,0.300783419702788,"CDK1",1
"R-HSA-2033519","R-HSA-2033519","Activated point mutants of FGFR2","1/112","17/2914",0.487348062681704,0.56815620298961,0.300783419702788,"FGF7",1
"R-HSA-2173782","R-HSA-2173782","Binding and Uptake of Ligands by Scavenger Receptors","1/112","17/2914",0.487348062681704,0.56815620298961,0.300783419702788,"HSP90AA1",1
"R-HSA-399719","R-HSA-399719","Trafficking of AMPA receptors","1/112","17/2914",0.487348062681704,0.56815620298961,0.300783419702788,"MDM2",1
"R-HSA-399721","R-HSA-399721","Glutamate binding, activation of AMPA receptors and synaptic plasticity","1/112","17/2914",0.487348062681704,0.56815620298961,0.300783419702788,"MDM2",1
"R-HSA-4570464","R-HSA-4570464","SUMOylation of RNA binding proteins","1/112","17/2914",0.487348062681704,0.56815620298961,0.300783419702788,"UBE2I",1
"R-HSA-5250941","R-HSA-5250941","Negative epigenetic regulation of rRNA expression","1/112","17/2914",0.487348062681704,0.56815620298961,0.300783419702788,"SIRT1",1
"R-HSA-5607761","R-HSA-5607761","Dectin-1 mediated noncanonical NF-kB signaling","1/112","17/2914",0.487348062681704,0.56815620298961,0.300783419702788,"RELA",1
"R-HSA-1234176","R-HSA-1234176","Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha","1/112","18/2914",0.507167536958421,0.584270709806829,0.309314482888937,"HIF1A",1
"R-HSA-168273","R-HSA-168273","Influenza Viral RNA Transcription and Replication","1/112","18/2914",0.507167536958421,0.584270709806829,0.309314482888937,"HSP90AA1",1
"R-HSA-190241","R-HSA-190241","FGFR2 ligand binding and activation","1/112","18/2914",0.507167536958421,0.584270709806829,0.309314482888937,"FGF7",1
"R-HSA-5610783","R-HSA-5610783","Degradation of GLI2 by the proteasome","1/112","18/2914",0.507167536958421,0.584270709806829,0.309314482888937,"GSK3B",1
"R-HSA-5654221","R-HSA-5654221","Phospholipase C-mediated cascade; FGFR2","1/112","18/2914",0.507167536958421,0.584270709806829,0.309314482888937,"FGF7",1
"R-HSA-8939243","R-HSA-8939243","RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known","1/112","18/2914",0.507167536958421,0.584270709806829,0.309314482888937,"EP300",1
"R-HSA-8953750","R-HSA-8953750","Transcriptional Regulation by E2F6","1/112","18/2914",0.507167536958421,0.584270709806829,0.309314482888937,"E2F1",1
"R-HSA-1368108","R-HSA-1368108","BMAL1:CLOCK,NPAS2 activates circadian gene expression","1/112","19/2914",0.526227355971079,0.600145579886748,0.317718681742792,"CREBBP",1
"R-HSA-1606322","R-HSA-1606322","ZBP1(DAI) mediated induction of type I IFNs","1/112","19/2914",0.526227355971079,0.600145579886748,0.317718681742792,"RELA",1
"R-HSA-2980766","R-HSA-2980766","Nuclear Envelope Breakdown","1/112","19/2914",0.526227355971079,0.600145579886748,0.317718681742792,"CDK1",1
"R-HSA-421270","R-HSA-421270","Cell-cell junction organization","1/112","19/2914",0.526227355971079,0.600145579886748,0.317718681742792,"CTNNB1",1
"R-HSA-5610785","R-HSA-5610785","GLI3 is processed to GLI3R by the proteasome","1/112","19/2914",0.526227355971079,0.600145579886748,0.317718681742792,"GSK3B",1
"R-HSA-73762","R-HSA-73762","RNA Polymerase I Transcription Initiation","1/112","19/2914",0.526227355971079,0.600145579886748,0.317718681742792,"KAT2B",1
"R-HSA-5696399","R-HSA-5696399","Global Genome Nucleotide Excision Repair (GG-NER)","2/112","46/2914",0.533912284140121,0.607893452059369,0.32182042607866,"PIAS1/UBE2I",2
"R-HSA-450321","R-HSA-450321","JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1","1/112","20/2914",0.544556383995686,0.613863560140592,0.324981017330179,"MAPK8",1
"R-HSA-5260271","R-HSA-5260271","Diseases of Immune System","1/112","20/2914",0.544556383995686,0.613863560140592,0.324981017330179,"RELA",1
"R-HSA-5339562","R-HSA-5339562","Uptake and actions of bacterial toxins","1/112","20/2914",0.544556383995686,0.613863560140592,0.324981017330179,"HSP90AA1",1
"R-HSA-5602358","R-HSA-5602358","Diseases associated with the TLR signaling cascade","1/112","20/2914",0.544556383995686,0.613863560140592,0.324981017330179,"RELA",1
"R-HSA-6783310","R-HSA-6783310","Fanconi Anemia Pathway","1/112","20/2914",0.544556383995686,0.613863560140592,0.324981017330179,"ATR",1
"R-HSA-9013507","R-HSA-9013507","NOTCH3 Activation and Transmission of Signal to the Nucleus","1/112","20/2914",0.544556383995686,0.613863560140592,0.324981017330179,"EGFR",1
"R-HSA-5663220","R-HSA-5663220","RHO GTPases Activate Formins","2/112","47/2914",0.545663039032999,0.614096027426577,0.325104086135694,"CDC42/SRC",2
"R-HSA-3781865","R-HSA-3781865","Diseases of glycosylation","1/112","21/2914",0.562182398160331,0.628538353353026,0.332749892267461,"NOTCH1",1
"R-HSA-3928663","R-HSA-3928663","EPHA-mediated growth cone collapse","1/112","21/2914",0.562182398160331,0.628538353353026,0.332749892267461,"SRC",1
"R-HSA-4615885","R-HSA-4615885","SUMOylation of DNA replication proteins","1/112","21/2914",0.562182398160331,0.628538353353026,0.332749892267461,"UBE2I",1
"R-HSA-73884","R-HSA-73884","Base Excision Repair","1/112","21/2914",0.562182398160331,0.628538353353026,0.332749892267461,"TDG",1
"R-HSA-112382","R-HSA-112382","Formation of RNA Pol II elongation complex ","1/112","22/2914",0.579132129030032,0.642224572355255,0.339995413362945,"CDC73",1
"R-HSA-180024","R-HSA-180024","DARPP-32 events","1/112","22/2914",0.579132129030032,0.642224572355255,0.339995413362945,"PPP1CA",1
"R-HSA-1839126","R-HSA-1839126","FGFR2 mutant receptor activation","1/112","22/2914",0.579132129030032,0.642224572355255,0.339995413362945,"FGF7",1
"R-HSA-187577","R-HSA-187577","SCF(Skp2)-mediated degradation of p27/p21","1/112","22/2914",0.579132129030032,0.642224572355255,0.339995413362945,"CCNE1",1
"R-HSA-75955","R-HSA-75955","RNA Polymerase II Transcription Elongation","1/112","22/2914",0.579132129030032,0.642224572355255,0.339995413362945,"CDC73",1
"R-HSA-68886","R-HSA-68886","M Phase","4/112","105/2914",0.581025848558085,0.643278618046451,0.340553427982609,"CDK1/HSP90AA1/MAPK1/MAPK3",4
"R-HSA-69306","R-HSA-69306","DNA Replication","2/112","51/2914",0.590599093514538,0.652817798665988,0.345603495821012,"CCNE1/E2F1",2
"R-HSA-201451","R-HSA-201451","Signaling by BMP","1/112","23/2914",0.595431299690003,0.653919720432499,0.346186856163524,"SMAD1",1
"R-HSA-3000170","R-HSA-3000170","Syndecan interactions","1/112","23/2914",0.595431299690003,0.653919720432499,0.346186856163524,"ITGB4",1
"R-HSA-69002","R-HSA-69002","DNA Replication Pre-Initiation","1/112","23/2914",0.595431299690003,0.653919720432499,0.346186856163524,"E2F1",1
"R-HSA-9020591","R-HSA-9020591","Interleukin-12 signaling","1/112","23/2914",0.595431299690003,0.653919720432499,0.346186856163524,"CDC42",1
"R-HSA-1169091","R-HSA-1169091","Activation of NF-kappaB in B cells","1/112","24/2914",0.6111046633824,0.665480782154537,0.352307313287554,"RELA",1
"R-HSA-168255","R-HSA-168255","Influenza Life Cycle","1/112","24/2914",0.6111046633824,0.665480782154537,0.352307313287554,"HSP90AA1",1
"R-HSA-912694","R-HSA-912694","Regulation of IFNA signaling","1/112","24/2914",0.6111046633824,0.665480782154537,0.352307313287554,"STAT1",1
"R-HSA-8953854","R-HSA-8953854","Metabolism of RNA","4/112","109/2914",0.611130831541087,0.665480782154537,0.352307313287554,"MAPK14/PRKCD/AKT1/MAPK11",4
"R-HSA-397014","R-HSA-397014","Muscle contraction","2/112","53/2914",0.611812977142074,0.665480782154537,0.352307313287554,"KAT2B/PAK1",2
"R-HSA-8856825","R-HSA-8856825","Cargo recognition for clathrin-mediated endocytosis","2/112","53/2914",0.611812977142074,0.665480782154537,0.352307313287554,"GRB2/EGFR",2
"R-HSA-388396","R-HSA-388396","GPCR downstream signalling","16/112","436/2914",0.622965471405986,0.676532566081024,0.358158157378903,"CDC42/PAK1/PIK3CA/PIK3R1/PRKCD/AKT1/AKT2/AKT3/GRB2/MAPK1/PIK3CG/SRC/EGFR/MAPK3/PPP1CA/CREB1",16
"R-HSA-5358351","R-HSA-5358351","Signaling by Hedgehog","2/112","55/2914",0.632188809058951,0.685457500442297,0.362883041598561,"GSK3B/CDC73",2
"R-HSA-3000157","R-HSA-3000157","Laminin interactions","1/112","26/2914",0.640668349735065,0.692449785292099,0.366584775976524,"ITGB4",1
"R-HSA-674695","R-HSA-674695","RNA Polymerase II Pre-transcription Events","1/112","26/2914",0.640668349735065,0.692449785292099,0.366584775976524,"CDC73",1
"R-HSA-68877","R-HSA-68877","Mitotic Prometaphase","2/112","56/2914",0.642063744523693,0.692859926843605,0.366801906015367,"CDK1/HSP90AA1",2
"R-HSA-174184","R-HSA-174184","Cdc20:Phospho-APC/C mediated degradation of Cyclin A","1/112","27/2914",0.654603649191323,0.701949196145413,0.371613789593883,"CDK1",1
"R-HSA-2122948","R-HSA-2122948","Activated NOTCH1 Transmits Signal to the Nucleus","1/112","27/2914",0.654603649191323,0.701949196145413,0.371613789593883,"NOTCH1",1
"R-HSA-445989","R-HSA-445989","TAK1 activates NFkB by phosphorylation and activation of IKKs complex","1/112","27/2914",0.654603649191323,0.701949196145413,0.371613789593883,"RELA",1
"R-HSA-69017","R-HSA-69017","CDK-mediated phosphorylation and removal of Cdc6","1/112","27/2914",0.654603649191323,0.701949196145413,0.371613789593883,"CCNE1",1
"R-HSA-179419","R-HSA-179419","APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint","1/112","28/2914",0.668003161242093,0.71407234477603,0.378031817036855,"CDK1",1
"R-HSA-6781823","R-HSA-6781823","Formation of TC-NER Pre-Incision Complex","1/112","28/2914",0.668003161242093,0.71407234477603,0.378031817036855,"EP300",1
"R-HSA-176409","R-HSA-176409","APC/C:Cdc20 mediated degradation of mitotic proteins","1/112","29/2914",0.680887307444756,0.724438601680692,0.383519741281798,"CDK1",1
"R-HSA-418597","R-HSA-418597","G alpha (z) signalling events","1/112","29/2914",0.680887307444756,0.724438601680692,0.383519741281798,"PRKCD",1
"R-HSA-5673000","R-HSA-5673000","RAF activation","1/112","29/2914",0.680887307444756,0.724438601680692,0.383519741281798,"SRC",1
"R-HSA-9612973","R-HSA-9612973","Autophagy","2/112","61/2914",0.688354088948019,0.731242194178425,0.387121581421824,"HSP90AA1/SRC",2
"R-HSA-168254","R-HSA-168254","Influenza Infection","1/112","30/2914",0.693275737796987,0.734183312387492,0.38867861730037,"HSP90AA1",1
"R-HSA-176814","R-HSA-176814","Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins","1/112","30/2914",0.693275737796987,0.734183312387492,0.38867861730037,"CDK1",1
"R-HSA-2022090","R-HSA-2022090","Assembly of collagen fibrils and other multimeric structures","1/112","31/2914",0.705187359630114,0.745639967856957,0.394743801473895,"ITGB4",1
"R-HSA-1474290","R-HSA-1474290","Collagen formation","1/112","32/2914",0.716640365430123,0.755388367535158,0.399904630443833,"ITGB4",1
"R-HSA-6782135","R-HSA-6782135","Dual incision in TC-NER","1/112","32/2914",0.716640365430123,0.755388367535158,0.399904630443833,"EP300",1
"R-HSA-6798695","R-HSA-6798695","Neutrophil degranulation","4/112","125/2914",0.717729709916103,0.755388367535158,0.399904630443833,"MAPK14/HSP90AA1/PRKCD/MAPK1",4
"R-HSA-5632684","R-HSA-5632684","Hedgehog 'on' state","1/112","33/2914",0.72765225962576,0.762302367226987,0.403564920448922,"CDC73",1
"R-HSA-6782210","R-HSA-6782210","Gap-filling DNA repair synthesis and ligation in TC-NER","1/112","33/2914",0.72765225962576,0.762302367226987,0.403564920448922,"EP300",1
"R-HSA-69052","R-HSA-69052","Switching of origins to a post-replicative state","1/112","33/2914",0.72765225962576,0.762302367226987,0.403564920448922,"CCNE1",1
"R-HSA-8856828","R-HSA-8856828","Clathrin-mediated endocytosis","2/112","66/2914",0.729665616518957,0.763239187831179,0.404060875792706,"GRB2/EGFR",2
"R-HSA-176408","R-HSA-176408","Regulation of APC/C activators between G1/S and early anaphase","1/112","34/2914",0.738239884381718,0.769846484936287,0.407558796624705,"CDK1",1
"R-HSA-2500257","R-HSA-2500257","Resolution of Sister Chromatid Cohesion","1/112","34/2914",0.738239884381718,0.769846484936287,0.407558796624705,"CDK1",1
"R-HSA-5576891","R-HSA-5576891","Cardiac conduction","1/112","35/2914",0.74841944443354,0.778082410219016,0.41191891758778,"KAT2B",1
"R-HSA-5610787","R-HSA-5610787","Hedgehog 'off' state","1/112","35/2914",0.74841944443354,0.778082410219016,0.41191891758778,"GSK3B",1
"R-HSA-2871837","R-HSA-2871837","FCERI mediated NF-kB activation","1/112","38/2914",0.776662718241869,0.806216094126263,0.426812965404087,"RELA",1
"R-HSA-6781827","R-HSA-6781827","Transcription-Coupled Nucleotide Excision Repair (TC-NER)","1/112","39/2914",0.785360136724801,0.814005491255796,0.430936693163664,"EP300",1
"R-HSA-372790","R-HSA-372790","Signaling by GPCR","16/112","486/2914",0.791965005895993,0.81893833553881,0.433548154174737,"CDC42/PAK1/PIK3CA/PIK3R1/PRKCD/AKT1/AKT2/AKT3/GRB2/MAPK1/PIK3CG/SRC/EGFR/MAPK3/PPP1CA/CREB1",16
"R-HSA-174143","R-HSA-174143","APC/C-mediated degradation of cell cycle proteins","1/112","40/2914",0.793721759224565,0.81893833553881,0.433548154174737,"CDK1",1
"R-HSA-453276","R-HSA-453276","Regulation of mitotic cell cycle","1/112","40/2914",0.793721759224565,0.81893833553881,0.433548154174737,"CDK1",1
"R-HSA-193704","R-HSA-193704","p75 NTR receptor-mediated signalling","2/112","76/2914",0.798566553593149,0.822692431345208,0.435535582576642,"MAPK8/RELA",2
"R-HSA-3928665","R-HSA-3928665","EPH-ephrin mediated repulsion of cells","1/112","42/2914",0.809488537931678,0.828935710014121,0.438840791070911,"SRC",1
"R-HSA-418346","R-HSA-418346","Platelet homeostasis","1/112","42/2914",0.809488537931678,0.828935710014121,0.438840791070911,"MAPK14",1
"R-HSA-6783783","R-HSA-6783783","Interleukin-10 signaling","1/112","42/2914",0.809488537931678,0.828935710014121,0.438840791070911,"STAT3",1
"R-HSA-909733","R-HSA-909733","Interferon alpha/beta signaling","1/112","42/2914",0.809488537931678,0.828935710014121,0.438840791070911,"STAT1",1
"R-HSA-4086400","R-HSA-4086400","PCP/CE pathway","1/112","44/2914",0.824060130915298,0.841330852221906,0.445402812644102,"ROR2",1
"R-HSA-69239","R-HSA-69239","Synthesis of DNA","1/112","44/2914",0.824060130915298,0.841330852221906,0.445402812644102,"CCNE1",1
"R-HSA-193648","R-HSA-193648","NRAGE signals death through JNK","1/112","48/2914",0.849970444028966,0.866487059533265,0.458720576354237,"MAPK8",1
"R-HSA-162909","R-HSA-162909","Host Interactions of HIV factors","1/112","49/2914",0.855833427374659,0.869863483561128,0.460508064302311,"LCK",1
"R-HSA-3000171","R-HSA-3000171","Non-integrin membrane-ECM interactions","1/112","49/2914",0.855833427374659,0.869863483561128,0.460508064302311,"ITGB4",1
"R-HSA-8951664","R-HSA-8951664","Neddylation","1/112","51/2914",0.866886661785445,0.879786760919157,0.465761473985601,"HIF1A",1
"R-HSA-1632852","R-HSA-1632852","Macroautophagy","1/112","53/2914",0.877099434393358,0.888828847334725,0.470548378817427,"SRC",1
"R-HSA-9020702","R-HSA-9020702","Interleukin-1 signaling","1/112","57/2914",0.895252354105848,0.905878494807401,0.479574507977988,"RELA",1
"R-HSA-204998","R-HSA-204998","Cell death signalling via NRAGE, NRIF and NADE","1/112","61/2914",0.91074440274655,0.920189159515773,0.487150612307316,"MAPK8",1
"R-HSA-73887","R-HSA-73887","Death Receptor Signalling","2/112","106/2914",0.921605212716741,0.929785140640263,0.492230750485584,"MAPK8/RELA",2
"R-HSA-418594","R-HSA-418594","G alpha (i) signalling events","5/112","217/2914",0.929955169464889,0.936823376034054,0.49595681120494,"PRKCD/MAPK1/SRC/PPP1CA/CREB1",5
"R-HSA-1474228","R-HSA-1474228","Degradation of the extracellular matrix","1/112","70/2914",0.937787671019474,0.943320341644958,0.499396322247601,"CAPN3",1
"R-HSA-418555","R-HSA-418555","G alpha (s) signalling events","1/112","73/2914",0.944854385980266,0.949029000351313,0.502418501497917,"SRC",1
"R-HSA-162906","R-HSA-162906","HIV Infection","1/112","80/2914",0.958398869169407,0.961217689372847,0.508871226199856,"LCK",1
"R-HSA-194840","R-HSA-194840","Rho GTPase cycle","1/112","106/2914",0.98548762843689,0.986344340773469,0.522173342931471,"CDC42",1
"R-HSA-1474244","R-HSA-1474244","Extracellular matrix organization","2/112","157/2914",0.986344340773469,0.986344340773469,0.522173342931471,"CAPN3/ITGB4",2
